Page last updated: 2024-12-05

glycyrrhetinic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth
FloraRankFlora DefinitionFamilyFamily Definition
GlycyrrhizagenusA genus of leguminous herbs or shrubs whose roots yield GLYCYRRHETINIC ACID and its derivative, CARBENOXOLONE.[MeSH]FabaceaeThe large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of beans belong to this family.[MeSH]

Cross-References

ID SourceID
PubMed CID10114
CHEMBL ID230006
CHEBI ID30853
CHEBI ID30853
SCHEMBL ID18540
MeSH IDM0009508

Synonyms (135)

Synonym
MLS002207101
(3beta,5beta,14beta)-3-hydroxy-11-oxoolean-12-en-29-oic acid
CBW ,
MLS001146949
18beta-glycyrrhetic acid
CHEBI:30853 ,
3beta-hydroxy-11-oxoolean-12-en-30-oic acid
471-53-4
glycyrrhetic acid
nsc-35350
uralenic acid
nsc-35347
stx-352
gm-1658
MLS000028748 ,
smr000058239
18-beta-glycyrrhetinic acid
arthrodont
enoloxone
18beta-glycyrrhetinic acid
bx-1
(3beta)-3-hydroxy-11-oxoolean-12-en-30-oic acid
enoxolona [inn-spanish]
olean-12-en-30-oic acid, 3beta-hydroxy-11-oxo-
glyciram
einecs 207-444-6
nsc 35347
brn 2229654
olean-12-en-29-oic acid, 3-hydroxy-11-oxo-, (3beta,20beta)-
rhetinic acid
jintan
18-beta-glycyrrhetic acid
enoxolone [inn:ban:dcf]
3-beta-hydroxy-11-oxoolean-12-en-30-oic acid
enoxolonum [inn-latin]
ccris 3962
alpha-glycyrrhetinic acid
(3beta,20beta)-3-hydroxy-11-oxo-olean-12-en-29-oic acid
olean-12-en-30-oic acid, 3-beta-hydroxy-11-oxo-
beta-glycyrrhetinic acid
hidermart (tn)
enoxolone (inn)
D00156
glycyrrhetinic acid (jan)
enoxolone; 18beta-glycyrrhetinic acid; 3?-hydroxy-11-oxo-18?,20?-olean-12-en-29-oic acid
S00284
NCGC00181115-01
C02283
18beta-glycyrrhetinic acid, 97%
NCGC00142473-03
acid, glycyrrhetinic
acid, uralenic
acid, rhetinic
acid, glycyrrhetic
AC-1925
CHEMBL230006 ,
(2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylic acid
bdbm50233538
G0149
LMPR0106150014
NCGC00017244-03
(5s,8s,15s,18s,1r,2r,10r,14r,20r)-18-hydroxy-1,2,5,8,15,19,19-heptamethyl-13-o xopentacyclo[12.8.0.0<2,11>.0<5,10>.0<15,20>]docos-11-ene-8-carboxylic acid
NCGC00258353-01
tox21_112726
tox21_200799
(2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylic acid;enoxolone
A827163
dtxsid9020669 ,
cas-471-53-4
tox21_110804
dtxcid50669
HMS2233P23
AKOS015960428
NCGC00017244-04
p540xa09dr ,
glycyrrhetinic acid [jan]
unii-p540xa09dr
enoxolonum
enoxolona
4-10-00-03775 (beilstein handbook reference)
18|a-glycyrrhetinic acid
enoxolone [who-dd]
enoxolone [ep impurity]
enoxolone [mi]
glycyrrhetinic acid [inci]
enoxolone [mart.]
enoxolone [ep monograph]
enoxolone [inn]
S2296
CCG-208506
AKOS016036757
SCHEMBL18540
KS-1262
enoxolone, glycyrrhetinic acid
Q-201057
(3?)-3-hydroxy-11-oxoolean-12-en-30-oic acid
18 beta-glycyrrhetintic acid
CS-W020624
(2s,4as,6as,6br,8ar,10s,12as,12br,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid
OPERA_ID_1048
3beta-hydroxy-11-oxo-18beta,20beta-olean-12-en-29-oic acid
3beta-hydroxy-11-oxoolean-12-en-29-oic acid
SR-01000721867-4
SR-01000721867-5
SR-01000721867-3
AC-8906
SR-01000721867-6
sr-01000721867
18beta-glycyrrhetinic acid, purum, >=97.0% (t)
enoxolone, european pharmacopoeia (ep) reference standard
3ss-hydroxy-11-oxo-18ss,20ss-olean-12-en-29-oic acid
enoxolone (synonym: 18ss--glycyrrhetinic acid)
NCGC00017244-06
DB13089
glycyrrhetinicacid
HY-N0180
Q5948038
enoxolone (glycyrrhetin)
107420-91-7
BRD-K96137854-001-17-1
hmdb: 0011628
chebi: 30853
(2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylicacid
gtpl11264
18 beta -glycyrrhetinic acid
glycyrrhetin ;18beta glycyrrhetinic acid
18-glycyrrhetinic acid
enoxolone 100 microg/ml in acetonitrile
enoxolone (mart.)
d03ax10
hidermart
15301-63-0
(3beta,20beta)-3-hydroxy-11-oxoolean-12-en-29-oic acid
enoxolone (ep monograph)
enoxolone (ep impurity)

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" In the present study, we show that GA induces actin disruption and has tumor cell-selective toxic properties, and that its selectivity is superior to those of all the clinically available antitumor agents tested."( Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: induction of actin disruption and tumor cell-selective toxicity.
Kamiie, K; Kidachi, Y; Noshita, T; Ryoyama, K; Umetsu, H; Yamaguchi, H; Yu, T, 2010
)
0.36

Bioavailability

ExcerptReferenceRelevance
"An early prediction of solubility in physiological media (PBS, SGF and SIF) is useful to predict qualitatively bioavailability and absorption of lead candidates."( Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Bharate, SS; Vishwakarma, RA, 2015
)
0.42
"Human carboxylesterase 2 (hCE2), one of the major carboxylesterases in the human intestine and various tumour tissues, plays important roles in the oral bioavailability and treatment outcomes of ester- or amide-containing drugs or prodrugs, such as anticancer agents CPT-11 (irinotecan) and LY2334737 (gemcitabine)."( Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2.
Ge, GB; Hao, DC; Hou, J; Jin, Q; Li, YG; Wang, P; Yang, L; Zhou, K; Zou, LW, 2016
)
0.43
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" The bioavailability of 29 was significantly improved in comparison with its aglycon."( Synthesis and anti-inflammatory activity of saponin derivatives of δ-oleanolic acid.
Chen, C; Cheng, K; Dai, L; Hu, K; Li, H; Liu, L; Sun, H; Wen, X; Xu, Q; Yuan, H, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (1 Product(s))

Product Categories

Product CategoryProducts
Beauty & Personal Care1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Eucerin Age Defense Lightweight Sunscreen Lotion for Face SPF 50 -- 2.5 fl ozEucerinBeauty & Personal Carecetearyl alcohol, cetyl alcohol, tocopherol, dibutyl adipate, behenyl alcohol, disodium edta, ethylcellulose, ethylhexylglycerin, tocopherol, glycerin, glyceryl behenate, glycyrrhetinic acid, dimethicone, l-carnitine, phenoxyethanol2024-11-29 10:47:42

Roles (2)

RoleDescription
immunomodulatorBiologically active substance whose activity affects or plays a role in the functioning of the immune system.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
pentacyclic triterpenoid
cyclic terpene ketoneAn alicyclic ketone in which the carbocyclic ring structure forms part of a terpene skeleton.
hydroxy monocarboxylic acidAny monocarboxylic acid which also contains a separate (alcoholic or phenolic) hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (61)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency15.81140.140911.194039.8107AID2451
Chain A, CruzipainTrypanosoma cruziPotency10.00000.002014.677939.8107AID1476
LuciferasePhotinus pyralis (common eastern firefly)Potency23.93410.007215.758889.3584AID588342
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency60.95913.189029.884159.4836AID1224846
SMAD family member 2Homo sapiens (human)Potency48.42150.173734.304761.8120AID1346859
SMAD family member 3Homo sapiens (human)Potency48.42150.173734.304761.8120AID1346859
TDP1 proteinHomo sapiens (human)Potency11.93330.000811.382244.6684AID686978; AID686979
GLI family zinc finger 3Homo sapiens (human)Potency36.00620.000714.592883.7951AID1259392
Microtubule-associated protein tauHomo sapiens (human)Potency33.99720.180013.557439.8107AID1460; AID1468
caspase 7, apoptosis-related cysteine proteaseHomo sapiens (human)Potency67.82310.013326.981070.7614AID1346978
progesterone receptorHomo sapiens (human)Potency60.44740.000417.946075.1148AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency37.33580.000214.376460.0339AID720692; AID720719
retinoid X nuclear receptor alphaHomo sapiens (human)Potency38.46260.000817.505159.3239AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency60.44740.001530.607315,848.9004AID1259401
farnesoid X nuclear receptorHomo sapiens (human)Potency33.89940.375827.485161.6524AID743217; AID743220
estrogen nuclear receptor alphaHomo sapiens (human)Potency30.71940.000229.305416,493.5996AID743069; AID743075; AID743077; AID743078; AID743079
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency10.84020.001024.504861.6448AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency27.89110.001019.414170.9645AID743094; AID743140; AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency17.18060.023723.228263.5986AID743222
caspase-3Homo sapiens (human)Potency67.82310.013326.981070.7614AID1346978
thyrotropin-releasing hormone receptorHomo sapiens (human)Potency34.28700.154917.870243.6557AID1346891
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency29.69740.057821.109761.2679AID1159526; AID1159528
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency25.61280.000323.4451159.6830AID743065; AID743067
heat shock protein beta-1Homo sapiens (human)Potency48.74280.042027.378961.6448AID743210; AID743228
serine/threonine-protein kinase PLK1Homo sapiens (human)Potency37.68580.168316.404067.0158AID720504
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency47.07230.000627.21521,122.0200AID743202; AID743219
gemininHomo sapiens (human)Potency16.06060.004611.374133.4983AID624296
DNA polymerase kappa isoform 1Homo sapiens (human)Potency33.58750.031622.3146100.0000AID588579
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency8.08750.005612.367736.1254AID624032
lamin isoform A-delta10Homo sapiens (human)Potency0.08910.891312.067628.1838AID1487
Cellular tumor antigen p53Homo sapiens (human)Potency38.45190.002319.595674.0614AID651631; AID720552
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)IC50 (µMol)40.00000.03201.46494.8000AID1617776
AcetylcholinesteraseElectrophorus electricus (electric eel)Ki100.00000.00121.25638.9000AID1153971
Aldo-keto reductase family 1 member B10Homo sapiens (human)IC50 (µMol)4.90000.00101.94459.6000AID697009
Glycogen phosphorylase, muscle formOryctolagus cuniculus (rabbit)IC50 (µMol)66.00000.01405.93249.0000AID404873
Pancreatic alpha-amylaseSus scrofa (pig)IC50 (µMol)200.00001.35304.31088.9300AID1465050
Beta-glucuronidaseEscherichia coli K-12IC50 (µMol)12.15001.60002.60003.6000AID1656434
Beta-glucuronidaseRattus norvegicus (Norway rat)IC50 (µMol)97.21002.80005.50007.8000AID1656453
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)IC50 (µMol)24.80000.00011.68479.3200AID1617774
Aldo-keto reductase family 1 member B1Homo sapiens (human)IC50 (µMol)280.00000.00101.191310.0000AID697010
Corticosteroid 11-beta-dehydrogenase isozyme 1 Rattus norvegicus (Norway rat)IC50 (µMol)0.09000.03000.17600.2920AID587118
Tyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)IC50 (µMol)20.00000.70004.58049.4500AID409687
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)IC50 (µMol)32.90000.00053.49849.7600AID409686; AID551434
Corticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)IC50 (µMol)0.18530.00411.066710.0000AID1202729; AID1484851; AID1634757; AID316048; AID352313; AID526983; AID587113; AID621453; AID758688
Tyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)IC50 (µMol)65.40000.29002.20754.2300AID551433
Prostaglandin G/H synthase 2Homo sapiens (human)IC50 (µMol)40.00000.00010.995010.0000AID1617780
Corticosteroid 11-beta-dehydrogenase isozyme 1Mus musculus (house mouse)IC50 (µMol)0.01240.00200.24103.7600AID1202731; AID1484848; AID1634754; AID316049; AID352314; AID758689
Corticosteroid 11-beta-dehydrogenase isozyme 2Rattus norvegicus (Norway rat)IC50 (µMol)0.36000.36000.36000.3600AID456094; AID587119
Corticosteroid 11-beta-dehydrogenase isozyme 2Homo sapiens (human)IC50 (µMol)0.10350.00040.63676.4300AID1202733; AID1484853; AID526982; AID587116; AID758686
CholinesteraseEquus caballus (horse)Ki100.00000.00203.45989.3700AID1153972
Tyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)IC50 (µMol)9.60000.31804.00429.6000AID1866108; AID551432
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)IC50 (µMol)10.00000.82003.90675.9000AID1464038
Lactoylglutathione lyaseMus musculus (house mouse)Ki0.29000.29000.29000.2900AID1604821
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)IC50 (µMol)0.54950.10472.71957.0795AID977603
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)Ki0.42000.08002.46889.8000AID977604
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)IC50 (µMol)0.52480.05002.37979.7000AID977600
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)Ki0.29000.04401.36305.0000AID977601
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Protein kinase C eta typeHomo sapiens (human)Kd0.25000.00040.28811.8000AID605339
Egl nine homolog 1Homo sapiens (human)EC50 (µMol)50.00006.11006.11006.1100AID1612308
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (437)

Processvia Protein(s)Taxonomy
lipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
phospholipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
apoptotic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell population proliferationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell migrationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
prostate gland developmentPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
regulation of epithelial cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of chemokine productionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of peroxisome proliferator activated receptor signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of keratinocyte differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell cyclePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of growthPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
hepoxilin biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
endocannabinoid signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cannabinoid biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxin A4 biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
retinoid metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
farnesol catabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
cellular detoxification of aldehydeAldo-keto reductase family 1 member B10Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
glucuronoside catabolic processBeta-glucuronidaseEscherichia coli K-12
carbohydrate metabolic processBeta-glucuronidaseEscherichia coli K-12
glucuronoside catabolic processBeta-glucuronidaseEscherichia coli K-12
negative regulation of endothelial cell proliferationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukocyte chemotaxis involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukocyte migration involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene production involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene metabolic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
humoral immune responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of angiogenesisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
positive regulation of bone mineralizationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
dendritic cell migrationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
glucose homeostasisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
long-chain fatty acid biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of fat cell differentiationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of insulin secretionPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of vascular wound healingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of wound healingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of inflammatory response to woundingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of cytokine production involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of cellular response to oxidative stressPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene A4 biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of reactive oxygen species biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of response to endoplasmic reticulum stressPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of sprouting angiogenesisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
positive regulation of leukocyte adhesion to arterial endothelial cellPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipoxin biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
retinoid metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
epithelial cell maturationAldo-keto reductase family 1 member B1Homo sapiens (human)
renal water homeostasisAldo-keto reductase family 1 member B1Homo sapiens (human)
carbohydrate metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
C21-steroid hormone biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
L-ascorbic acid biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
regulation of urine volumeAldo-keto reductase family 1 member B1Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
negative regulation of apoptotic processAldo-keto reductase family 1 member B1Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
fructose biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
cellular hyperosmotic salinity responseAldo-keto reductase family 1 member B1Homo sapiens (human)
metanephric collecting duct developmentAldo-keto reductase family 1 member B1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of cell population proliferationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of tumor necrosis factor-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of lipid storageTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
B cell differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
T cell differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
erythrocyte differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of epidermal growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of tyrosine phosphorylation of STAT proteinTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
glucose homeostasisTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of macrophage differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of gluconeogenesisTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of inflammatory responseTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of T cell receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of chemotaxisTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
regulation of type II interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of type II interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of interleukin-6-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of interleukin-2-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of interleukin-4-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of macrophage colony-stimulating factor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of positive thymic T cell selectionTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of JUN kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
actin cytoskeleton organizationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of endocytosisTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of vascular endothelial growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulum unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of intracellular protein transportTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cellular response to unfolded proteinTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of MAP kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of protein tyrosine kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of receptor catabolic processTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein phosphorylationProtein kinase C eta typeHomo sapiens (human)
signal transductionProtein kinase C eta typeHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationProtein kinase C eta typeHomo sapiens (human)
cell differentiationProtein kinase C eta typeHomo sapiens (human)
negative regulation of glial cell apoptotic processProtein kinase C eta typeHomo sapiens (human)
positive regulation of keratinocyte differentiationProtein kinase C eta typeHomo sapiens (human)
positive regulation of B cell receptor signaling pathwayProtein kinase C eta typeHomo sapiens (human)
positive regulation of NF-kappaB transcription factor activityProtein kinase C eta typeHomo sapiens (human)
positive regulation of glial cell proliferationProtein kinase C eta typeHomo sapiens (human)
protein kinase C signalingProtein kinase C eta typeHomo sapiens (human)
positive regulation of protein localization to plasma membraneProtein kinase C eta typeHomo sapiens (human)
regulation of bicellular tight junction assemblyProtein kinase C eta typeHomo sapiens (human)
peptidyl-serine phosphorylationProtein kinase C eta typeHomo sapiens (human)
intracellular signal transductionProtein kinase C eta typeHomo sapiens (human)
lung developmentCorticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)
steroid catabolic processCorticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)
MAPK cascadeTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
hematopoietic progenitor cell differentiationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of humoral immune response mediated by circulating immunoglobulinTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
G protein-coupled receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
positive regulation of cell population proliferationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of cell population proliferationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of angiogenesisTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
peptidyl-tyrosine phosphorylationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cytokine-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cell differentiationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
platelet formationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
T cell costimulationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of interleukin-6 productionTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of tumor necrosis factor productionTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of mast cell activation involved in immune responseTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
positive regulation of cell adhesion mediated by integrinTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
megakaryocyte developmentTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
T cell proliferationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of T cell proliferationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
natural killer cell mediated cytotoxicityTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
regulation of apoptotic processTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of MAPK cascadeTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
regulation of B cell differentiationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of peptidyl-tyrosine phosphorylationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
T cell receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
B cell receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of T cell receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosolTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
platelet aggregationTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
negative regulation of inflammatory response to woundingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
epididymis developmentTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
regulation of G1/S transition of mitotic cell cycleTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
intracellular signal transductionTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
mitotic cell cycleTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
MAPK cascadeTyrosine-protein phosphatase non-receptor type 7Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 7Homo sapiens (human)
prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 2Homo sapiens (human)
embryo implantationProstaglandin G/H synthase 2Homo sapiens (human)
learningProstaglandin G/H synthase 2Homo sapiens (human)
memoryProstaglandin G/H synthase 2Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell population proliferationProstaglandin G/H synthase 2Homo sapiens (human)
response to xenobiotic stimulusProstaglandin G/H synthase 2Homo sapiens (human)
response to nematodeProstaglandin G/H synthase 2Homo sapiens (human)
response to fructoseProstaglandin G/H synthase 2Homo sapiens (human)
response to manganese ionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 2Homo sapiens (human)
bone mineralizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fever generationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic plasticityProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of synaptic transmission, dopaminergicProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin secretionProstaglandin G/H synthase 2Homo sapiens (human)
response to estradiolProstaglandin G/H synthase 2Homo sapiens (human)
response to lipopolysaccharideProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationProstaglandin G/H synthase 2Homo sapiens (human)
response to vitamin DProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to heatProstaglandin G/H synthase 2Homo sapiens (human)
response to tumor necrosis factorProstaglandin G/H synthase 2Homo sapiens (human)
maintenance of blood-brain barrierProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of protein import into nucleusProstaglandin G/H synthase 2Homo sapiens (human)
hair cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of apoptotic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vasoconstrictionProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
decidualizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle cell proliferationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of inflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
response to glucocorticoidProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of calcium ion transportProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergicProstaglandin G/H synthase 2Homo sapiens (human)
response to fatty acidProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to mechanical stimulusProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to lead ionProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to ATPProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to hypoxiaProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to non-ionic osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to fluid shear stressProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of transforming growth factor beta productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fibroblast growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of platelet-derived growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of neuroinflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to homocysteineProstaglandin G/H synthase 2Homo sapiens (human)
response to angiotensinProstaglandin G/H synthase 2Homo sapiens (human)
response to hypoxiaCorticosteroid 11-beta-dehydrogenase isozyme 2Homo sapiens (human)
regulation of blood volume by renal aldosteroneCorticosteroid 11-beta-dehydrogenase isozyme 2Homo sapiens (human)
female pregnancyCorticosteroid 11-beta-dehydrogenase isozyme 2Homo sapiens (human)
response to xenobiotic stimulusCorticosteroid 11-beta-dehydrogenase isozyme 2Homo sapiens (human)
response to foodCorticosteroid 11-beta-dehydrogenase isozyme 2Homo sapiens (human)
response to insulinCorticosteroid 11-beta-dehydrogenase isozyme 2Homo sapiens (human)
cortisol metabolic processCorticosteroid 11-beta-dehydrogenase isozyme 2Homo sapiens (human)
response to glucocorticoidCorticosteroid 11-beta-dehydrogenase isozyme 2Homo sapiens (human)
glucocorticoid metabolic processCorticosteroid 11-beta-dehydrogenase isozyme 2Homo sapiens (human)
DNA damage checkpoint signalingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
triglyceride metabolic processTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
epidermal growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
integrin-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
axonogenesisTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
brain developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
heart developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
fibroblast growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
hormone-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cytokine-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cerebellar cortex formationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
platelet formationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
T cell costimulationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of chondrocyte differentiationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of type I interferon productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
microvillus organizationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of interferon-beta productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of interleukin-6 productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of tumor necrosis factor productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of cell adhesion mediated by integrinTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of cell adhesion mediated by integrinTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
multicellular organism growthTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
organ growthTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
megakaryocyte developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
atrioventricular canal developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
ERBB signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
hormone metabolic processTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
glucose homeostasisTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of protein-containing complex assemblyTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of ossificationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of mitotic cell cycleTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of glucose importTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of insulin secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of protein export from nucleusTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of hormone secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
platelet-derived growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
neurotrophin TRK receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
ephrin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
multicellular organismal reproductive processTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
genitalia developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
inner ear developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
homeostasis of number of cells within a tissueTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of cortisol secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
Bergmann glial cell differentiationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of growth hormone secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
face morphogenesisTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
intestinal epithelial cell migrationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cellular response to epidermal growth factor stimulusTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
microtubule polymerizationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
positive regulation of protein phosphorylationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
regulation of cytokinesisPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
protein peptidyl-prolyl isomerizationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
response to hypoxiaPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
regulation of protein phosphorylationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
regulation of mitotic nuclear divisionPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
regulation of gene expressionPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
neuron differentiationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
regulation of protein stabilityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of protein bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
positive regulation of protein bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
positive regulation of protein dephosphorylationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of protein catabolic processPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
positive regulation of GTPase activityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
synapse organizationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
protein stabilizationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of SMAD protein signal transductionPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadePeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
positive regulation of canonical Wnt signaling pathwayPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
regulation of protein localization to nucleusPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of amyloid-beta formationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of cell motilityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
regulation of cell growthProlyl hydroxylase EGLN2Homo sapiens (human)
response to hypoxiaProlyl hydroxylase EGLN2Homo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineProlyl hydroxylase EGLN2Homo sapiens (human)
intracellular estrogen receptor signaling pathwayProlyl hydroxylase EGLN2Homo sapiens (human)
regulation of neuron apoptotic processProlyl hydroxylase EGLN2Homo sapiens (human)
cell redox homeostasisProlyl hydroxylase EGLN2Homo sapiens (human)
positive regulation of protein catabolic processProlyl hydroxylase EGLN2Homo sapiens (human)
cellular response to hypoxiaProlyl hydroxylase EGLN2Homo sapiens (human)
response to hypoxiaEgl nine homolog 1Homo sapiens (human)
intracellular iron ion homeostasisEgl nine homolog 1Homo sapiens (human)
intracellular oxygen homeostasisEgl nine homolog 1Homo sapiens (human)
negative regulation of DNA-binding transcription factor activityEgl nine homolog 1Homo sapiens (human)
regulation of angiogenesisEgl nine homolog 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIEgl nine homolog 1Homo sapiens (human)
negative regulation of cyclic-nucleotide phosphodiesterase activityEgl nine homolog 1Homo sapiens (human)
cardiac muscle tissue morphogenesisEgl nine homolog 1Homo sapiens (human)
heart trabecula formationEgl nine homolog 1Homo sapiens (human)
ventricular septum morphogenesisEgl nine homolog 1Homo sapiens (human)
labyrinthine layer developmentEgl nine homolog 1Homo sapiens (human)
response to nitric oxideEgl nine homolog 1Homo sapiens (human)
regulation of modification of postsynaptic structureEgl nine homolog 1Homo sapiens (human)
regulation protein catabolic process at postsynapseEgl nine homolog 1Homo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineEgl nine homolog 1Homo sapiens (human)
cellular response to hypoxiaEgl nine homolog 1Homo sapiens (human)
response to hypoxiaProlyl hydroxylase EGLN3Homo sapiens (human)
apoptotic processProlyl hydroxylase EGLN3Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processProlyl hydroxylase EGLN3Homo sapiens (human)
DNA damage responseProlyl hydroxylase EGLN3Homo sapiens (human)
protein hydroxylationProlyl hydroxylase EGLN3Homo sapiens (human)
regulation of cell population proliferationProlyl hydroxylase EGLN3Homo sapiens (human)
regulation of neuron apoptotic processProlyl hydroxylase EGLN3Homo sapiens (human)
cellular response to hypoxiaProlyl hydroxylase EGLN3Homo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineProlyl hydroxylase EGLN3Homo sapiens (human)
xenobiotic metabolic processSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
monoatomic ion transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
organic anion transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
bile acid and bile salt transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
heme catabolic processSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
sodium-independent organic anion transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
transmembrane transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
regulation of erythrocyte differentiationTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
xenobiotic metabolic processSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
monoatomic ion transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
organic anion transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
bile acid and bile salt transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
prostaglandin transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
heme catabolic processSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
sodium-independent organic anion transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
transmembrane transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
thyroid hormone transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (127)

Processvia Protein(s)Taxonomy
iron ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
calcium ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
protein bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 13S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 15-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 9S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
retinal dehydrogenase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
aldo-keto reductase (NADPH) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B10Homo sapiens (human)
alcohol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
geranylgeranyl reductase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
indanol dehydrogenase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
hydrolase activity, hydrolyzing O-glycosyl compoundsBeta-glucuronidaseEscherichia coli K-12
beta-glucuronidase activityBeta-glucuronidaseEscherichia coli K-12
hydrolase activity, acting on glycosyl bondsBeta-glucuronidaseEscherichia coli K-12
identical protein bindingBeta-glucuronidaseEscherichia coli K-12
carbohydrate bindingBeta-glucuronidaseEscherichia coli K-12
arachidonate 5-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonate 12(S)-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
iron ion bindingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
protein bindingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
hydrolase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
retinal dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B1Homo sapiens (human)
electron transfer activityAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin H2 endoperoxidase reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glyceraldehyde oxidoreductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
L-glucuronate reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glycerol dehydrogenase [NADP+] activityAldo-keto reductase family 1 member B1Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
integrin bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
syntaxin bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
STAT family protein bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
RNA bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
zinc ion bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
enzyme bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
ephrin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein phosphatase 2A bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein kinase activityProtein kinase C eta typeHomo sapiens (human)
diacylglycerol-dependent serine/threonine kinase activityProtein kinase C eta typeHomo sapiens (human)
diacylglycerol-dependent, calcium-independent serine/threonine kinase activityProtein kinase C eta typeHomo sapiens (human)
protein bindingProtein kinase C eta typeHomo sapiens (human)
ATP bindingProtein kinase C eta typeHomo sapiens (human)
enzyme bindingProtein kinase C eta typeHomo sapiens (human)
small GTPase bindingProtein kinase C eta typeHomo sapiens (human)
metal ion bindingProtein kinase C eta typeHomo sapiens (human)
protein serine kinase activityProtein kinase C eta typeHomo sapiens (human)
protein serine/threonine kinase activityProtein kinase C eta typeHomo sapiens (human)
protein homodimerization activityCorticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)
7-beta-hydroxysteroid dehydrogenase (NADP+) activityCorticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)
NADP bindingCorticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)
11-beta-hydroxysteroid dehydrogenase (NADP+) activityCorticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)
cortisol dehydrogenase activityCorticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)
steroid bindingCorticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)
phosphotyrosine residue bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
transmembrane receptor protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
SH3 domain bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
SH2 domain bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cell adhesion molecule bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
phosphorylation-dependent protein bindingTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 7Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 7Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 7Homo sapiens (human)
peroxidase activityProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 2Homo sapiens (human)
protein bindingProstaglandin G/H synthase 2Homo sapiens (human)
enzyme bindingProstaglandin G/H synthase 2Homo sapiens (human)
heme bindingProstaglandin G/H synthase 2Homo sapiens (human)
protein homodimerization activityProstaglandin G/H synthase 2Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 2Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 2Homo sapiens (human)
steroid bindingCorticosteroid 11-beta-dehydrogenase isozyme 2Homo sapiens (human)
NAD bindingCorticosteroid 11-beta-dehydrogenase isozyme 2Homo sapiens (human)
11-beta-hydroxysteroid dehydrogenase (NAD+) activityCorticosteroid 11-beta-dehydrogenase isozyme 2Homo sapiens (human)
phosphotyrosine residue bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
phosphoprotein phosphatase activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
signaling receptor complex adaptor activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cell adhesion molecule bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
peptide hormone receptor bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
molecular adaptor activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
peptidyl-prolyl cis-trans isomerase activityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
cytoskeletal motor activityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
protein bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
beta-catenin bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
cis-trans isomerase activityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
mitogen-activated protein kinase kinase bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
GTPase activating protein bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
tau protein bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
phosphoserine residue bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
phosphothreonine residue bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
phosphoprotein bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
ubiquitin ligase activator activityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
protein bindingProlyl hydroxylase EGLN2Homo sapiens (human)
ferrous iron bindingProlyl hydroxylase EGLN2Homo sapiens (human)
2-oxoglutarate-dependent dioxygenase activityProlyl hydroxylase EGLN2Homo sapiens (human)
oxygen sensor activityProlyl hydroxylase EGLN2Homo sapiens (human)
L-ascorbic acid bindingProlyl hydroxylase EGLN2Homo sapiens (human)
peptidyl-proline 4-dioxygenase activityProlyl hydroxylase EGLN2Homo sapiens (human)
hypoxia-inducible factor-proline dioxygenase activityProlyl hydroxylase EGLN2Homo sapiens (human)
protein bindingEgl nine homolog 1Homo sapiens (human)
ferrous iron bindingEgl nine homolog 1Homo sapiens (human)
2-oxoglutarate-dependent dioxygenase activityEgl nine homolog 1Homo sapiens (human)
enzyme bindingEgl nine homolog 1Homo sapiens (human)
L-ascorbic acid bindingEgl nine homolog 1Homo sapiens (human)
peptidyl-proline dioxygenase activityEgl nine homolog 1Homo sapiens (human)
hypoxia-inducible factor-proline dioxygenase activityEgl nine homolog 1Homo sapiens (human)
peptidyl-proline 4-dioxygenase activityEgl nine homolog 1Homo sapiens (human)
protein bindingProlyl hydroxylase EGLN3Homo sapiens (human)
2-oxoglutarate-dependent dioxygenase activityProlyl hydroxylase EGLN3Homo sapiens (human)
L-ascorbic acid bindingProlyl hydroxylase EGLN3Homo sapiens (human)
peptidyl-proline 4-dioxygenase activityProlyl hydroxylase EGLN3Homo sapiens (human)
hypoxia-inducible factor-proline dioxygenase activityProlyl hydroxylase EGLN3Homo sapiens (human)
ferrous iron bindingProlyl hydroxylase EGLN3Homo sapiens (human)
serine-type endopeptidase inhibitor activitySolute carrier organic anion transporter family member 1B3Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1B3Homo sapiens (human)
bile acid transmembrane transporter activitySolute carrier organic anion transporter family member 1B3Homo sapiens (human)
sodium-independent organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1B3Homo sapiens (human)
iron ion bindingTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
calcium ion bindingTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
2-oxoglutarate-dependent dioxygenase activityTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
L-ascorbic acid bindingTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
hypoxia-inducible factor-proline dioxygenase activityTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
procollagen-proline 4-dioxygenase activityTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
bile acid transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
prostaglandin transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
sodium-independent organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
thyroid hormone transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (62)

Processvia Protein(s)Taxonomy
nucleusPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytoskeletonPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
adherens junctionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
focal adhesionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular exosomePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular regionAldo-keto reductase family 1 member B10Homo sapiens (human)
lysosomeAldo-keto reductase family 1 member B10Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B10Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B10Homo sapiens (human)
mitochondrionAldo-keto reductase family 1 member B10Homo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
cytosolBeta-glucuronidaseEscherichia coli K-12
protein-containing complexBeta-glucuronidaseEscherichia coli K-12
extracellular regionPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
extracellular spacePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelopePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelope lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nucleoplasmPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
cytosolPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear matrixPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear membranePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
secretory granule lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
perinuclear region of cytoplasmPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
ficolin-1-rich granule lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelopePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
extracellular spaceAldo-keto reductase family 1 member B1Homo sapiens (human)
nucleoplasmAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
extracellular exosomeAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
nucleoplasmTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
nucleusTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial matrixTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial cristaTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
sorting endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmic side of endoplasmic reticulum membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmProtein kinase C eta typeHomo sapiens (human)
cytosolProtein kinase C eta typeHomo sapiens (human)
plasma membraneProtein kinase C eta typeHomo sapiens (human)
cell-cell junctionProtein kinase C eta typeHomo sapiens (human)
extracellular exosomeProtein kinase C eta typeHomo sapiens (human)
endoplasmic reticulum membraneCorticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)
membraneCorticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)
endoplasmic reticulum membraneCorticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)
intracellular membrane-bounded organelleCorticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
extracellular regionTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
nucleusTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
nucleoplasmTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
nucleolusTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cell-cell junctionTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
membraneTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
specific granule lumenTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
extracellular exosomeTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
tertiary granule lumenTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
alpha-beta T cell receptor complexTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)
nucleoplasmTyrosine-protein phosphatase non-receptor type 7Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 7Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 7Homo sapiens (human)
cytoplasmic side of plasma membraneTyrosine-protein phosphatase non-receptor type 7Homo sapiens (human)
microtubule cytoskeletonTyrosine-protein phosphatase non-receptor type 7Homo sapiens (human)
mitotic spindleTyrosine-protein phosphatase non-receptor type 7Homo sapiens (human)
nuclear inner membraneProstaglandin G/H synthase 2Homo sapiens (human)
nuclear outer membraneProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulumProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum lumenProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 2Homo sapiens (human)
caveolaProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
protein-containing complexProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum membraneCorticosteroid 11-beta-dehydrogenase isozyme 2Homo sapiens (human)
intracellular membrane-bounded organelleCorticosteroid 11-beta-dehydrogenase isozyme 2Homo sapiens (human)
intracellular membrane-bounded organelleCorticosteroid 11-beta-dehydrogenase isozyme 2Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
nucleusTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
nucleoplasmTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
glutamatergic synapsePeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
postsynaptic cytosolPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
nucleusPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
nucleoplasmPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
cytoplasmPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
cytosolPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
nuclear speckPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
midbodyPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
ciliary basal bodyPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
nucleusPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
cytosolPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
nucleusProlyl hydroxylase EGLN2Homo sapiens (human)
nucleoplasmProlyl hydroxylase EGLN2Homo sapiens (human)
nucleusProlyl hydroxylase EGLN2Homo sapiens (human)
cytoplasmProlyl hydroxylase EGLN2Homo sapiens (human)
cytoplasmEgl nine homolog 1Homo sapiens (human)
cytosolEgl nine homolog 1Homo sapiens (human)
postsynaptic densityEgl nine homolog 1Homo sapiens (human)
intracellular membrane-bounded organelleEgl nine homolog 1Homo sapiens (human)
glutamatergic synapseEgl nine homolog 1Homo sapiens (human)
nucleusEgl nine homolog 1Homo sapiens (human)
cytoplasmEgl nine homolog 1Homo sapiens (human)
nucleusProlyl hydroxylase EGLN3Homo sapiens (human)
nucleoplasmProlyl hydroxylase EGLN3Homo sapiens (human)
cytoplasmProlyl hydroxylase EGLN3Homo sapiens (human)
cytosolProlyl hydroxylase EGLN3Homo sapiens (human)
cytoplasmProlyl hydroxylase EGLN3Homo sapiens (human)
nucleusProlyl hydroxylase EGLN3Homo sapiens (human)
plasma membraneSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
basal plasma membraneSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
basolateral plasma membraneSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
endoplasmic reticulum membraneTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
endoplasmic reticulumTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
plasma membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
basal plasma membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
basolateral plasma membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (437)

Assay IDTitleYearJournalArticle
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347411qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID300499Cytotoxicity against human HCT8 cells2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Anti-tumor agents 255: novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents.
AID1069930Induction of apoptosis in human NCI-H460 cells assessed as activation of caspase 9/3 at 12.5 to 50 uM after 24 hrs by Western blot analysis2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID1617774Inhibition of human recombinant 5-LOX expressed in insect cells assessed as decrease in production of 5-HPETE and 5-HETE using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by ferric io2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID526982Inhibition of human recombinant 11beta-HSD2 expressed in HEK293 cells assessed as conversion of [1,2,6,7-3H]-cortisol to cortisone by scintillation counting2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
AID1484850Inhibition of full-length human 11beta-HSD1 expressed in HEK293 microsomal fraction at 1 uM using [3H]cortisone as substrate after 2 hr by scintillation proximity assay relative to control2017European journal of medicinal chemistry, Jul-28, Volume: 135Synthesis of selective 11β-HSD1 inhibitors based on dammarane scaffold.
AID1568247Antiproliferative activity against human MCF7 cells incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Sep-15, Volume: 178Synthesis and biological activity of glycyrrhetinic acid derivatives as antitumor agents.
AID1431437Cytotoxicity against human 8505C cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1634742Reduction in mmD expression in Bacillus subtilis ATCC 6051 at 0.5 times MIC by qRT-PCR analysis relative to control2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID1602161Antiviral activity against EBV infected in human Raji cells assessed as reduction in viral genome copy numbers by qRT-PCR analysis2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis and structure-activity relationship studies of water-soluble β-cyclodextrin-glycyrrhetinic acid conjugates as potential anti-influenza virus agents.
AID528057Cytotoxicity against human A2780 cells after 96 hrs by SRB assay2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
AID548047Cytotoxicity against human A253 cells after 96 hrs by sulforhodamine B assay2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
AID1414765Cytotoxicity activity against mouse LLC cells assessed as cell growth inhibition after 48 hrs by MTT assay2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids.
AID1578452Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 96 hrs by SRB assay2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis and cytotoxicity of BODIPY FL labelled triterpenoids.
AID300503Cytotoxicity against human LN-Cap cells2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Anti-tumor agents 255: novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents.
AID303882Inhibition of basal ER-mediated transcription activity in MELN cells by measuring luciferase activity at 2 uM after 18 hrs2007Journal of medicinal chemistry, Nov-29, Volume: 50, Issue:24
New novobiocin analogues as antiproliferative agents in breast cancer cells and potential inhibitors of heat shock protein 90.
AID1484849Inhibition of full-length mouse 11beta-HSD1 expressed in HEK293 microsomal fraction at 1 uM using [3H]cortisone as substrate after 1 hr by scintillation proximity assay relative to control2017European journal of medicinal chemistry, Jul-28, Volume: 135Synthesis of selective 11β-HSD1 inhibitors based on dammarane scaffold.
AID548055Cytotoxicity against human Lipo cells after 96 hrs by sulforhodamine B assay2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
AID1612308Inhibition of PHD (unknown origin) expressed in mouse NIH/3T3 cells harboring HRE-driven luciferase gene assessed as transactivation of HIF1alpha after 6 hrs by luciferase reporter gene assay2018Journal of natural products, 10-26, Volume: 81, Issue:10
Triterpenoid Hydroxamates as HIF Prolyl Hydrolase Inhibitors.
AID1634723Antibacterial activity against methicillin-resistant Staphylococcus aureus by microdilution assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID316048Inhibition of human 11beta-HSD12008Bioorganic & medicinal chemistry letters, Feb-15, Volume: 18, Issue:4
Discovery of novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling.
AID623144Growth inhibition in apoptosis-sensitive human Hs683 after 3 days by MTT assay2011Journal of medicinal chemistry, Oct-13, Volume: 54, Issue:19
N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
AID1243945Cytotoxicity against human 518A2 cells assessed as cell survival after 96 hrs by SRB assay2015European journal of medicinal chemistry, Aug-28, Volume: 101Incorporation of a Michael acceptor enhances the antitumor activity of triterpenoic acids.
AID1153972Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate after 20 mins measured for 1 min interval for 30 mins by Ellman's method2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Amino derivatives of glycyrrhetinic acid as potential inhibitors of cholinesterases.
AID733155Inhibition of MAPK p38 in mouse LPS-induced RAW264.7 cells at 75 uM incubated for 2 hrs prior to LPS-challenge measured after 30 mins by Western blot analysis2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Discovery of a potential anti-inflammatory agent: 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile.
AID587121Inhibition of rat 11beta-HSD1 at 10 uM2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
AID605339Binding affinity to recombinant human PKCeta in after 2 hrs by microequilibrium dialysis assay2010Journal of natural products, Oct-22, Volume: 73, Issue:10
An optimized immunoaffinity fluorescent method for natural product target elucidation.
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1202730Inhibition of mouse 11beta-HSD2 overexpressed in microsomal fraction of HEK293 cells using [3H]-cortisol as substrate by scintillation proximity assay in presence of NAD+2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Hupehenols A-E, selective 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors from Viburnum hupehense.
AID678717Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-benzyloxyquinoline as substrate after 30 mins2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID401472Antihepatotoxic activity against 1.5 hrs galactosamine pretreatment-induced cytotoxicity in Wistar rat hepatocytes assessed as glutamic-pyruvic transaminase activity at 0.1 mg/ml after 30 hrs relative to control
AID717314Inhibition of chymotrypsin-like activity of human 20S proteasome using Suc-Leu-Leu-Val-Tyr-AMC as substrate by fluorometric assay2012Bioorganic & medicinal chemistry letters, Dec-15, Volume: 22, Issue:24
Synthesis and biological evaluation of novel spin labeled 18β-glycyrrhetinic acid derivatives.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID622024Activation of caspase-like activity of 20S proteasome in human U373 cells at 90 uM after 2 days by bioluminescence assay2011Journal of medicinal chemistry, Oct-13, Volume: 54, Issue:19
N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
AID659363Cytotoxicity against human HepG2(2.2.15) cells2012Bioorganic & medicinal chemistry letters, May-15, Volume: 22, Issue:10
Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
AID548056Cytotoxicity against human MCF7 cells after 96 hrs by sulforhodamine B assay2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
AID587123Inhibition of human recombinant 11beta-HSD2 expressed in HEK293 cells assessed as conversion of [1,2-[3H]cortisone to cortisol at 1 uM after 10 mins by scintillation counting2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
AID1414764Cytotoxicity activity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids.
AID1484854Selectivity index, ratio of IC50 for human full length 11beta-HSD2 expressed in HEK293 microsomal fraction to IC50 for human full length 11beta-HSD1 expressed in HEK293 microsomal fraction2017European journal of medicinal chemistry, Jul-28, Volume: 135Synthesis of selective 11β-HSD1 inhibitors based on dammarane scaffold.
AID678721Metabolic stability in human liver microsomes assessed as GSH adduct formation at 100 uM after 90 mins by HPLC-MS analysis2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID456095Inhibition of human recombinant 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [1,2-3H]cortisone to cortisol at 1 uM after 10 mins by scintillation counting2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases.
AID456098Inhibition of 11beta-HSD1 in rat liver assessed as cortisone level at 10 uM2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases.
AID1453349Inhibition of recombinant human 11beta-HSD2 expressed in HEK293 cells assessed as residual activity at 20 uM using cortisol as substrate after 10 mins in presence of radiolabeled tracer substrate by scintillation counting method relative to control2017Bioorganic & medicinal chemistry letters, 07-01, Volume: 27, Issue:13
Phenylbenzenesulfonates and -sulfonamides as 17β-hydroxysteroid dehydrogenase type 2 inhibitors: Synthesis and SAR-analysis.
AID1153971Inhibition of Electrophorus electricus AChE using acetylthiocholine iodide as substrate after 20 mins measured for 1 min interval for 30 mins by Ellman's method2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Amino derivatives of glycyrrhetinic acid as potential inhibitors of cholinesterases.
AID1193494Thermodynamic equilibrium solubility, log S of the compound in simulated gastric fluid at pH 1.2 at RT after 4 hrs by 96 well plate method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID1202731Inhibition of mouse 11beta-HSD1 overexpressed in microsomal fraction of HEK293 cells assessed as formation of [3H]-cortisol from [3H]-cortisone by scintillation proximity assay in presence of NADPH2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Hupehenols A-E, selective 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors from Viburnum hupehense.
AID307007Cytotoxicity against human LNCAP cells at 20 ug/mL by sulforhodamine B assay2007Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents.
AID300495Cytotoxicity against human KB cells2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Anti-tumor agents 255: novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents.
AID528059Cytotoxicity against human A549 cells after 96 hrs by SRB assay2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
AID658064Membranolytic activity in human ECV304 cells assessed as leakage of intracellular lactate dehydrogenase after 2 hrs by spectrophotometry2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Saponins can perturb biologic membranes and reduce the surface tension of aqueous solutions: a correlation?
AID1431433Cytotoxicity against human A2780 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID623145Growth inhibition in apoptosis-sensitive human PC3 after 3 days by MTT assay2011Journal of medicinal chemistry, Oct-13, Volume: 54, Issue:19
N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
AID603953In-vivo plasma to lung partition coefficients of the compound, logP(lung) in rat2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
AID551435Inhibition of recombinant HePTP2011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs.
AID733165Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated TNF-alpha mRNA expression at 75 uM incubated for 2 hrs prior to LPS-challenge measured after 8 hrs by quantitative real time PCR analysis2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Discovery of a potential anti-inflammatory agent: 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile.
AID1515734Cytotoxicity against human K562/ADR cells assessed as cell growth inhibition after 48 hrs by MTT assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
Synthesis and antitumor activity of fluorouracil - oleanolic acid/ursolic acid/glycyrrhetinic acid conjugates.
AID664366Cytotoxicity against mouse RAW264.7 cells at 100 uM after 8 hrs by MTT assay2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Bryonolic acid transcriptional control of anti-inflammatory and antioxidant genes in macrophages in vitro and in vivo.
AID1617777Inhibition of human recombinant N-terminal His-tagged 15-LOX2 expressed in Escherichia coli assessed as residual activity at 42 uM using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID745024Antifilarial activity against female adult Brugia malayi assessed as inhibition of motility after 24 hrs by microscopic analysis2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Glycyrrhetinic acid and its analogs: a new class of antifilarial agents.
AID1634725Antibacterial activity against Pseudomonas aeruginosa at 100 uM measured after 5 to 6 hrs by microdilution assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID300493Cytotoxicity against human KB cells by sulforhodamine B assay2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Anti-tumor agents 255: novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents.
AID1602165Solubility of the compound in water2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis and structure-activity relationship studies of water-soluble β-cyclodextrin-glycyrrhetinic acid conjugates as potential anti-influenza virus agents.
AID745023Antifilarial activity against microfilariae Brugia malayi assessed as inhibition of motility after 24 hrs by microscopic analysis2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Glycyrrhetinic acid and its analogs: a new class of antifilarial agents.
AID1617779Inhibition of ovine recombinant COX1 assessed as residual activity at 42 uM using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1617776Inhibition of human recombinant N-terminal His-tagged 15-LOX2 expressed in Escherichia coli using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by ferric ion oxidation-xylenol orange as2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID717315Growth inhibition of human KBVIN cells by SRB assay2012Bioorganic & medicinal chemistry letters, Dec-15, Volume: 22, Issue:24
Synthesis and biological evaluation of novel spin labeled 18β-glycyrrhetinic acid derivatives.
AID354420Cytotoxicity against human Raji cells assessed as cell viability at 32 nmol after 48 hrs by trypan blue assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Polyprenylated benzophenones from Garcinia assigu and their potential cancer chemopreventive activities.
AID1917384Cytoprotective activity against human HDF cells assessed as increase in cell viability at 10 uM incubated for 24 hrs by MTT assay2022Bioorganic & medicinal chemistry letters, 11-15, Volume: 76Photoprotective effect of 18β-glycyrrhetinic acid derivatives against ultra violet (UV)-B-Induced skin aging.
AID1416422Cytotoxicity against mouse RAW264.7 cells assessed as cell viability at 40 uM after 24 hrs by MTT assay relative to control2017MedChemComm, Jul-01, Volume: 8, Issue:7
18α-Glycyrrhetinic acid monoglucuronide as an anti-inflammatory agent through suppression of the NF-κB and MAPK signaling pathway.
AID1586628Selectivity ratio of IC50 for cisplatin-resistant human SKOV3/DDP cells to IC50 for cisplatin sensitive human SKOV3 cells2018Bioorganic & medicinal chemistry letters, 12-15, Volume: 28, Issue:23-24
Glycyrrhetinic acid derivatives containing aminophosphonate ester species as multidrug resistance reversers that block the NF-κB pathway and cell proliferation.
AID1586619Antiproliferative activity against human MGC803 cells after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 12-15, Volume: 28, Issue:23-24
Glycyrrhetinic acid derivatives containing aminophosphonate ester species as multidrug resistance reversers that block the NF-κB pathway and cell proliferation.
AID548052Cytotoxicity against human HCT116 cells after 96 hrs by sulforhodamine B assay2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
AID490291Down regulation of beta-actin protein expression in mouse r/m HM-SFME-1 cells at IC50 after 8 hrs by Western blotting2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: induction of actin disruption and tumor cell-selective toxicity.
AID528062Cytotoxicity against human HCT116 cells after 96 hrs by SRB assay2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
AID528061Cytotoxicity against human FADU cells after 96 hrs by SRB assay2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
AID1500920Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production by measuring nitrite level at 20 uM pretreated for 2 hrs followed by LPS challenge measured after 24 hrs by Griess assay2017European journal of medicinal chemistry, Oct-20, Volume: 139Novel unsaturated glycyrrhetic acids derivatives: Design, synthesis and anti-inflammatory activity.
AID1586621Antiproliferative activity against human MG63 cells after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 12-15, Volume: 28, Issue:23-24
Glycyrrhetinic acid derivatives containing aminophosphonate ester species as multidrug resistance reversers that block the NF-κB pathway and cell proliferation.
AID623140Growth inhibition in apoptosis-resistant human A549 after 3 days by MTT assay2011Journal of medicinal chemistry, Oct-13, Volume: 54, Issue:19
N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
AID1431434Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1431438Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID528068Cytotoxicity against human SW480 cells after 96 hrs by SRB assay2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
AID1568249Antiproliferative activity against human HeLa cells incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Sep-15, Volume: 178Synthesis and biological activity of glycyrrhetinic acid derivatives as antitumor agents.
AID678716Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using diethoxyfluorescein as substrate after 30 mins2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID456097Inhibition of human recombinant 11beta-HSD2 expressed in HEK293 cells assessed as oxidation of [1,2,6,7-3H]cortisol to cortisone at 1 uM after 10 mins by scintillation counting2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases.
AID659365Selectivity index, ratio of CC50 for human HepG2(2.2.15) cells to IC50 for HBV by hepatitis B surface antigen release detection assay2012Bioorganic & medicinal chemistry letters, May-15, Volume: 22, Issue:10
Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
AID717318Growth inhibition of human A549 cells by SRB assay2012Bioorganic & medicinal chemistry letters, Dec-15, Volume: 22, Issue:24
Synthesis and biological evaluation of novel spin labeled 18β-glycyrrhetinic acid derivatives.
AID1431436Cytotoxicity against human A549 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1414761Cytotoxicity activity against human A375 cells assessed as cell growth inhibition after 48 hrs by MTT assay2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids.
AID1515731Cytotoxicity against human A549/T cells assessed as cell growth inhibition after 48 hrs by MTT assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
Synthesis and antitumor activity of fluorouracil - oleanolic acid/ursolic acid/glycyrrhetinic acid conjugates.
AID1250813Antiproliferative activity against human MCF7 cells after 48 hrs by CCK-8 assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Design, synthesis, and biofunctional evaluation of novel pentacyclic triterpenes bearing O-[4-(1-piperazinyl)-4-oxo-butyryl moiety as antiproliferative agents.
AID548051Cytotoxicity against human FADU cells after 96 hrs by sulforhodamine B assay2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
AID1693911Cytotoxicity against human Epidermoid carcinoma cell line2021Bioorganic & medicinal chemistry, 01-15, Volume: 30Soloxolone methyl, as a 18βH-glycyrrhetinic acid derivate, may result in endoplasmic reticulum stress to induce apoptosis in breast cancer cells.
AID1903448Anti-asthmatic activity against ovalbumin-induced asthmatic mouse model assessed as decrease in IL-13 level in BALF at 20 mg/kg, po administered once daily for 7 days by ELISA
AID300496Cytotoxicity against human KB-VIN cells2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Anti-tumor agents 255: novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents.
AID697011Selectivity ratio of IC50 for human recombinant AKR1B1 to IC50 for human AKR1B102011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID406996Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol at 40 uM2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries.
AID1389862Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
Discovery of 18β-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance.
AID1634757Inhibition of human microsomal 11beta-HSD1 overexpressed in HEK293 cells using [3H]-cortisone as substrate assessed as formation of [3H]-cortisol using [3H]cortisone by scintillation proximity assay in presence of NADPH2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Limonoids and Triterpenoids as 11β-HSD1 Inhibitors from Walsura robusta.
AID587111Inhibition of human recombinant 11beta-HSD1 expressed in HEK293 cells assessed as residual conversion of [1,2-[3H]cortisone to cortisol at 1000 nM after 10 mins by scintillation counting2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
AID587114Inhibition of human 11beta-HSD2 expressed in HEK293 cells assessed as residual conversion of [1,2,6,7-[3H]cortisol to cortisone at 1000 nM after 10 mins by scintillation counting2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
AID354419Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 0.32 nmol after 48 hrs relative to TPA2003Journal of natural products, Feb, Volume: 66, Issue:2
Polyprenylated benzophenones from Garcinia assigu and their potential cancer chemopreventive activities.
AID1069935Cell cycle arrest in human NCI-H460 cells assessed as accumulation at sub-G1 phase after 1 hr by propidium iodide staining-based flow cytometric analysis2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID1484855Selectivity index, ratio of IC50 for mouse full length 11beta-HSD2 expressed in HEK293 microsomal fraction to IC50 for mouse full length 11beta-HSD1 expressed in HEK293 microsomal fraction2017European journal of medicinal chemistry, Jul-28, Volume: 135Synthesis of selective 11β-HSD1 inhibitors based on dammarane scaffold.
AID758685Inhibition of human 11beta-HSD1 expressed in HEK293 cell microsomes assessed as inhibition of [3H]cortisone conversion to [3H]cortisol at 1 uM by scintillation proximity assay2013European journal of medicinal chemistry, Jul, Volume: 65Discovery and structure-activity relationships of ent-Kaurene diterpenoids as potent and selective 11β-HSD1 inhibitors: potential impact in diabetes.
AID605337Drug uptake in human HeLa cells assessed as subcellular localization in endoplasmic reticulum at 25 uM after 6 hrs by live cell microscopic analysis2010Journal of natural products, Oct-22, Volume: 73, Issue:10
An optimized immunoaffinity fluorescent method for natural product target elucidation.
AID1602166Water/n-BuOH partition coefficient, log P of the compound2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis and structure-activity relationship studies of water-soluble β-cyclodextrin-glycyrrhetinic acid conjugates as potential anti-influenza virus agents.
AID1688021Cytotoxicity against human PC-3 cells assessed as reduction in cell viability after 96 hrs by MTT assay2020European journal of medicinal chemistry, Feb-15, Volume: 188A 18β-glycyrrhetinic acid conjugate with Vorinostat degrades HDAC3 and HDAC6 with improved antitumor effects.
AID745025Antifilarial activity against female adult Brugia malayi assessed as inhibition of MTT reduction at LC100 concentration after 24 hrs2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Glycyrrhetinic acid and its analogs: a new class of antifilarial agents.
AID1484852Inhibition of full-length mouse 11beta-HSD2 expressed in HEK293 microsomal fraction using [3H]cortisone as substrate after 1 hr by scintillation proximity assay2017European journal of medicinal chemistry, Jul-28, Volume: 135Synthesis of selective 11β-HSD1 inhibitors based on dammarane scaffold.
AID528066Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
AID1193492Thermodynamic equilibrium solubility, log S of the compound in water at RT after 4 hrs by 96 well plate method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID1634721Antibacterial activity against Streptomyces scabiei CGMCC4.7610246 by microdilution assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID1578454Cytotoxicity against human FADU cells assessed as reduction in cell viability incubated for 96 hrs by SRB assay2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis and cytotoxicity of BODIPY FL labelled triterpenoids.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID300497Cytotoxicity against human A549 cells2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Anti-tumor agents 255: novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents.
AID717317Growth inhibition of human DU145 cells by SRB assay2012Bioorganic & medicinal chemistry letters, Dec-15, Volume: 22, Issue:24
Synthesis and biological evaluation of novel spin labeled 18β-glycyrrhetinic acid derivatives.
AID297145Inhibition of SARS coronavirus-induced cytopathogenicity in Vero E6 cells at 20 uM2007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus.
AID316049Inhibition of mouse 11beta-HSD12008Bioorganic & medicinal chemistry letters, Feb-15, Volume: 18, Issue:4
Discovery of novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling.
AID1586615Antiproliferative activity against human HL-7702 cells after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 12-15, Volume: 28, Issue:23-24
Glycyrrhetinic acid derivatives containing aminophosphonate ester species as multidrug resistance reversers that block the NF-κB pathway and cell proliferation.
AID1617778Inhibition of ovine recombinant COX1 assessed as decrease in formation of PGE2 using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1372437Antitussive activity in ammonia liquor-induced cough ICR mouse model assessed as reduction in cough frequency at 50 mg/kg, po treated with ammonia 1 hr before and 1 to 5 hrs after test compound dosing measured for 3 mins relative to control2018Bioorganic & medicinal chemistry, 01-01, Volume: 26, Issue:1
Antitussive and expectorant activities of licorice and its major compounds.
AID587119Inhibition of rat renal 11beta-HSD22011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
AID1465050Inhibition of porcine pancreatic alpha-amylase using starch as substrate preincubated for 15 mins followed by substrate addition measured after 10 mins by dinitrosalicylic acid reagent based assay2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Pentacyclic triterpenes as α-glucosidase and α-amylase inhibitors: Structure-activity relationships and the synergism with acarbose.
AID1069950Induction of apoptosis in human NCI-H460 cells assessed as downregulation of cyclin D1 protein expression at 12.5 to 50 uM after 24 hrs by Western blot analysis2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID1389861Antiproliferative activity against human A549 cells after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
Discovery of 18β-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance.
AID587113Inhibition of human recombinant 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [1,2-[3H]cortisone to cortisol after 10 mins by scintillation counting2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
AID659368Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication2012Bioorganic & medicinal chemistry letters, May-15, Volume: 22, Issue:10
Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
AID750462Antiviral activity against pseudo HCV infected in human 293T cells assessed as inhibition of HCV pseudo particles entry at 10 uM after 72 hrs by luciferase reporter gene assay2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Development of oleanane-type triterpenes as a new class of HCV entry inhibitors.
AID401471Antihepatotoxic activity against 1.5 hrs galactosamine pretreatment-induced cytotoxicity in Wistar rat hepatocytes assessed as glutamic-pyruvic transaminase activity at 0.01 mg/ml after 30 hrs relative to control
AID418484Inhibition of LPS-induced TNFalpha release in mouse RAW264.7 cells pretreated 1 hr before LPS challenge by enzyme immunoassay2009Bioorganic & medicinal chemistry, Apr-01, Volume: 17, Issue:7
Synthesis, anti-inflammatory, and antioxidant activities of 18beta-glycyrrhetinic acid derivatives as chemical mediators and xanthine oxidase inhibitors.
AID733163Inhibition of IkappaB phosphorylation in mouse RAW264.7 cells assessed as decrease in LPS-induced phospho-IkappaBalpha level at 75 uM incubated for 2 hrs prior to LPS-challenge measured after 30 mins by Western blot analysis2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Discovery of a potential anti-inflammatory agent: 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile.
AID354417Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 16 nmol after 48 hrs relative to TPA2003Journal of natural products, Feb, Volume: 66, Issue:2
Polyprenylated benzophenones from Garcinia assigu and their potential cancer chemopreventive activities.
AID1656434Inhibition of Escherichia coli beta-glucuronidase2020European journal of medicinal chemistry, Feb-01, Volume: 187Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.
AID297146Inhibition of SARS coronavirus-induced cytopathogenicity in Vero E6 cells at 10 uM2007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus.
AID1586626Growth inhibition of cisplatin sensitive human SKOV3 cells after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 12-15, Volume: 28, Issue:23-24
Glycyrrhetinic acid derivatives containing aminophosphonate ester species as multidrug resistance reversers that block the NF-κB pathway and cell proliferation.
AID1651329Neuroprotective activity against CoCl2-induced neuronal injury in rat PC12 cells2020Bioorganic & medicinal chemistry letters, 02-15, Volume: 30, Issue:4
Application of tandem biotransformation for biosynthesis of new pentacyclic triterpenoid derivatives with neuroprotective effect.
AID528054Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
AID659364Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release2012Bioorganic & medicinal chemistry letters, May-15, Volume: 22, Issue:10
Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
AID343737Inhibition of chymotrypsin-like activity of human 20S proteasome2008Bioorganic & medicinal chemistry, Jul-15, Volume: 16, Issue:14
Synthesis and proteasome inhibition of glycyrrhetinic acid derivatives.
AID587116Inhibition of human 11beta-HSD2 expressed in HEK293 cells assessed as conversion of [1,2,6,7-[3H]cortisol to cortisone after 10 mins by scintillation counting2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
AID365156Binding affinity to photoactivated rhodopsin in bovine retinal rod outer-segment membranes assessed as induction of extra receptor MII state stabilization at 250 uM by UV/visible difference spectroscopy2008Journal of medicinal chemistry, Sep-11, Volume: 51, Issue:17
Modulating G-protein coupled receptor/G-protein signal transduction by small molecules suggested by virtual screening.
AID1414759Cytotoxicity activity against human MDA-MB-231 cells assessed as cell growth inhibition after 48 hrs by MTT assay2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids.
AID1662292Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of NO production preincubated for 1 hr followed by LPS stimulation measured after 24 hrs by Griess reagent based assay2020Bioorganic & medicinal chemistry, 06-01, Volume: 28, Issue:11
Microbial transformation of glycyrrhetinic acid derivatives by Bacillus subtilis ATCC 6633 and Bacillus megaterium CGMCC 1.1741.
AID1515732Cytotoxicity against human MCF7/ADR cells assessed as cell growth inhibition after 48 hrs by MTT assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
Synthesis and antitumor activity of fluorouracil - oleanolic acid/ursolic acid/glycyrrhetinic acid conjugates.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID623139Chemical stability of the compound in MEM cell culture medium after 7 days by HPLC analysis2011Journal of medicinal chemistry, Oct-13, Volume: 54, Issue:19
N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
AID356351Inhibition of testerone 5-alpha-reductase at 25 ug/mL2003Journal of natural products, Aug, Volume: 66, Issue:8
Phenolic constituents from Dalbergia cochinchinensis.
AID1247579Antiviral activity against HCV psuedoparticles infected in human Huh7 cells assessed as inhibition of virus entry at 10 uM using Bright Glo reagent after 72 hrs by Luciferase reporter gene assay2015European journal of medicinal chemistry, Sep-18, Volume: 102Synthesis and biological evaluation of ring A and/or C expansion and opening echinocystic acid derivatives for anti-HCV entry inhibitors.
AID343739Inhibition of caspase-like activity of human 20S proteasome2008Bioorganic & medicinal chemistry, Jul-15, Volume: 16, Issue:14
Synthesis and proteasome inhibition of glycyrrhetinic acid derivatives.
AID1617781Inhibition of human recombinant COX2 expressed in baculovirus infected sf21 cells assessed as residual activity at 42 uM using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis r2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1500918Cytotoxicity against mouse RAW264.7 cells assessed as cell viability at 40 uM after 24 hrs by MTT assay (Rvb = 100%)2017European journal of medicinal chemistry, Oct-20, Volume: 139Novel unsaturated glycyrrhetic acids derivatives: Design, synthesis and anti-inflammatory activity.
AID1243949Cytotoxicity against human MCF7 cells assessed as cell survival after 96 hrs by SRB assay2015European journal of medicinal chemistry, Aug-28, Volume: 101Incorporation of a Michael acceptor enhances the antitumor activity of triterpenoic acids.
AID1604821Inhibition of recombinant mouse Glyoxalase-1 expressed in Escherichia coli BL21 (DE3) pLysS cells using GSH and MGO as substrate by Dixon plot2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
Recent advances in the discovery and development of glyoxalase I inhibitors.
AID587122Inhibition of human recombinant 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [1,2-[3H]cortisone to cortisol at 1 uM after 10 mins by scintillation counting2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
AID758684Inhibition of mouse 11beta-HSD1 expressed in HEK293 cell microsomes assessed as inhibition of [3H]cortisone conversion to [3H]cortisol at 1 uM by scintillation proximity assay2013European journal of medicinal chemistry, Jul, Volume: 65Discovery and structure-activity relationships of ent-Kaurene diterpenoids as potent and selective 11β-HSD1 inhibitors: potential impact in diabetes.
AID697010Inhibition of reductase activity of N-terminal 6His-tagged human recombinant AKR1B1 expressed in Escherichia coli BL21(DE3) assessed as assessed as pyridine-3-aldehyde reduction2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID690629Induction of apoptosis in human A549 cells assessed as apoptotic effect at 90 uM after 24 to 48 hrs by trypan blue cell counting analysis2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
Synthesis and antitumor activity of ring A modified glycyrrhetinic acid derivatives.
AID300501Cytotoxicity against human PC3 cells2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Anti-tumor agents 255: novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents.
AID1634735Effect on lytM expression in Staphylococcus aureus ATCC 25923 at 0.5 times MIC by qRT-PCR analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID1069949Induction of apoptosis in human NCI-H460 cells assessed as downregulation of cyclin E protein expression at 12.5 to 50 uM after 24 hrs by Western blot analysis2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID758686Inhibition of human 11beta-HSD22013European journal of medicinal chemistry, Jul, Volume: 65Discovery and structure-activity relationships of ent-Kaurene diterpenoids as potent and selective 11β-HSD1 inhibitors: potential impact in diabetes.
AID1389863Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
Discovery of 18β-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance.
AID1602164Lipophilicity, log P of the compound2019European journal of medicinal chemistry, Mar-15, Volume: 166Synthesis and structure-activity relationship studies of water-soluble β-cyclodextrin-glycyrrhetinic acid conjugates as potential anti-influenza virus agents.
AID659367Selectivity index, ratio of CC50 for human HepG2(2.2.15) cells to IC50 for HBV by hepatitis B e-antigen release detection assay2012Bioorganic & medicinal chemistry letters, May-15, Volume: 22, Issue:10
Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
AID1634720Antibacterial activity against Bacillus subtilis ATCC 6051 by microdilution assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID587117Selectivity ratio of IC50 for human 11beta-HSD1 to IC50 for human 11beta-HSD22011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
AID401474Cytotoxicity in Wistar rat hepatocytes assessed as glutamic-pyruvic transaminase activity at 0.01 mg/ml after 30 hrs
AID1193498Thermodynamic equilibrium solubility, log S of the compound simulated gastric fluid at pH 1.2 at RT after 24 hrs by shake-flask method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID1568246Antiproliferative activity against human A549 cells incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Sep-15, Volume: 178Synthesis and biological activity of glycyrrhetinic acid derivatives as antitumor agents.
AID1391717Antiviral activity against Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBeAg secretion after 3 days by ELISA2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
AID1193499Thermodynamic equilibrium solubility, log S of the compound simulated intestinal fluid at pH 6.8 at RT after 24 hrs by shake-flask method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID548054Cytotoxicity against human HT-29 cells after 96 hrs by sulforhodamine B assay2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
AID1917385Cytoprotective activity against UV-B irradiation induced human HDF cells assessed as increase in cell viability at 10 uM incubated for 24 hrs by MTT assay2022Bioorganic & medicinal chemistry letters, 11-15, Volume: 76Photoprotective effect of 18β-glycyrrhetinic acid derivatives against ultra violet (UV)-B-Induced skin aging.
AID354418Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 3.2 nmol after 48 hrs relative to TPA2003Journal of natural products, Feb, Volume: 66, Issue:2
Polyprenylated benzophenones from Garcinia assigu and their potential cancer chemopreventive activities.
AID551433Inhibition of recombinant SHP12011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs.
AID1416423Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 production at 10 to 40 uM preincubated for 2 hrs followed by LPS addition measured after 20 hrs by ELISA2017MedChemComm, Jul-01, Volume: 8, Issue:7
18α-Glycyrrhetinic acid monoglucuronide as an anti-inflammatory agent through suppression of the NF-κB and MAPK signaling pathway.
AID401473Antihepatotoxic activity against 1.5 hrs galactosamine pretreatment-induced cytotoxicity in Wistar rat hepatocytes assessed as glutamic-pyruvic transaminase activity at 1 mg/ml after 30 hrs relative to control
AID623274Cytostatic activity against human A549 cells assessed as absence of induction of apoptosis at 100 uM after 48 to 72 hrs by TUNEL-based flow cytometric analysis2011Journal of medicinal chemistry, Oct-13, Volume: 54, Issue:19
N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
AID977603pIC50 values for sodium fluorescein (10 uM) uptake in OATP1B3-transfected CHO cells2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1903447Anti-asthmatic activity against ovalbumin-induced asthmatic mouse model assessed as decrease in IL-5 level in BALF at 20 mg/kg, po administered once daily for 7 days by ELISA
AID551434Inhibition of recombinant PTP1B2011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs.
AID1866108Inhibition of SHP2 (unknown origin)2022Journal of medicinal chemistry, 02-24, Volume: 65, Issue:4
Strategies Targeting Protein Tyrosine Phosphatase SHP2 for Cancer Therapy.
AID526978Inhibition of human recombinant 11beta-HSD2 expressed in HEK293 cells assessed as residual conversion of [1,2,6,7-3H]-cortisol to cortisone at 1 uM by scintillation counting2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
AID548049Cytotoxicity against human A549 cells after 96 hrs by sulforhodamine B assay2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
AID297148Inhibition of SARS virus-induced cytopathogenicity in Vero E6 cells at 1 uM2007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus.
AID1515730Cytotoxicity against human LO2 cells assessed as cell growth inhibition after 48 hrs by MTT assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
Synthesis and antitumor activity of fluorouracil - oleanolic acid/ursolic acid/glycyrrhetinic acid conjugates.
AID303883Inhibition of estradiol-induced ER-mediated transcription in MELN cells by measuring luciferase activity at 2 uM after 18 hrs2007Journal of medicinal chemistry, Nov-29, Volume: 50, Issue:24
New novobiocin analogues as antiproliferative agents in breast cancer cells and potential inhibitors of heat shock protein 90.
AID1464035Antiproliferative activity against human PC3 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT assay2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Conjugates of 18β-glycyrrhetinic acid derivatives with 3-(1H-benzo[d]imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability.
AID1515727Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 48 hrs by MTT assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
Synthesis and antitumor activity of fluorouracil - oleanolic acid/ursolic acid/glycyrrhetinic acid conjugates.
AID1069940Induction of c-Jun N-terminal kinase phosphorylation in human NCI-H460 cells at 12.5 to 50 uM after 24 hrs by Western blot analysis2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID733166Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated IL-1beta mRNA expression at 75 uM incubated for 2 hrs prior to LPS-challenge measured after 8 hrs by quantitative real time PCR analysis2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Discovery of a potential anti-inflammatory agent: 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile.
AID1586617Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 12-15, Volume: 28, Issue:23-24
Glycyrrhetinic acid derivatives containing aminophosphonate ester species as multidrug resistance reversers that block the NF-κB pathway and cell proliferation.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID623268Growth inhibition in mouse B16F10 after 3 days by MTT assay2011Journal of medicinal chemistry, Oct-13, Volume: 54, Issue:19
N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
AID1515729Cytotoxicity against human K562 cells assessed as cell growth inhibition after 48 hrs by MTT assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
Synthesis and antitumor activity of fluorouracil - oleanolic acid/ursolic acid/glycyrrhetinic acid conjugates.
AID758689Inhibition of mouse 11beta-HSD1 expressed in HEK293 cell microsomes assessed as inhibition of [3H]cortisone conversion to [3H]cortisol by scintillation proximity assay2013European journal of medicinal chemistry, Jul, Volume: 65Discovery and structure-activity relationships of ent-Kaurene diterpenoids as potent and selective 11β-HSD1 inhibitors: potential impact in diabetes.
AID1431432Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1578455Cytotoxicity against mouse NIH/3T3 cells assessed as reduction in cell viability incubated for 96 hrs by SRB assay2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis and cytotoxicity of BODIPY FL labelled triterpenoids.
AID548057Cytotoxicity against human SW1736 cells after 96 hrs by sulforhodamine B assay2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
AID490286Antiproliferative activity against mouse SFME cells after 24 hrs by MTT assay2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: induction of actin disruption and tumor cell-selective toxicity.
AID1285099Inhibition of CE2 in human liver microsomes using fluorescein diacetate as substrate preincubated for 10 mins followed by substrate addition measured after 30 mins by LC-UV analysis2016European journal of medicinal chemistry, Apr-13, Volume: 112Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2.
AID1202733Inhibition of human 11beta-HSD2 overexpressed in microsomal fraction of HEK293 cells using [3H]-cortisol as substrate by scintillation proximity assay in presence of NAD+2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Hupehenols A-E, selective 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors from Viburnum hupehense.
AID307002Cytotoxicity against human MRC5 cells by sulforhodamine B assay2007Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents.
AID527944Antiproliferative activity against human Bel7402 cells after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellular carcinoma agents.
AID548053Cytotoxicity against human HCT8 cells after 96 hrs by sulforhodamine B assay2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
AID352314Inhibition of mouse 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay in presence of NADPH2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Structure-based virtual screening for identification of novel 11beta-HSD1 inhibitors.
AID1484848Inhibition of full-length mouse 11beta-HSD1 expressed in HEK293 microsomal fraction using [3H]cortisone as substrate after 1 hr by scintillation proximity assay2017European journal of medicinal chemistry, Jul-28, Volume: 135Synthesis of selective 11β-HSD1 inhibitors based on dammarane scaffold.
AID526983Inhibition of human recombinant 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [1,2-3H]-cortisone to cortisol by scintillation counting2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
AID587118Inhibition of rat hepatic 11beta-HSD12011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
AID608127Cytotoxicity against human NTUB1 cells after 72 hrs by MTT assay2011Bioorganic & medicinal chemistry, Jul-15, Volume: 19, Issue:14
18β-Glycyrrhetinic acid derivatives induced mitochondrial-mediated apoptosis through reactive oxygen species-mediated p53 activation in NTUB1 cells.
AID733175Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production incubated for 2 hrs prior to LPS-challenge measured after 24 hrs by Griess method2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Discovery of a potential anti-inflammatory agent: 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile.
AID1465051Inhibition of yeast alpha-glucosidase using 4-nitrophenyl-alpha-D-glucopyranoside as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Pentacyclic triterpenes as α-glucosidase and α-amylase inhibitors: Structure-activity relationships and the synergism with acarbose.
AID733154Inhibition of JNK phosphorylation in mouse LPS-induced RAW264.7 cells at 75 uM incubated for 2 hrs prior to LPS-challenge measured after 30 mins by Western blot analysis2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Discovery of a potential anti-inflammatory agent: 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile.
AID1634722Antibacterial activity against Staphylococcus aureus ATCC 25923 by microdilution assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID528069Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
AID623141Growth inhibition in apoptosis-resistant human SK-MEL-28 after 3 days by MTT assay2011Journal of medicinal chemistry, Oct-13, Volume: 54, Issue:19
N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
AID406997Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries.
AID1069933Cytotoxicity against human A549 cells assessed as cell viability after 24 hrs by XTT assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID1243947Cytotoxicity against human A549 cells assessed as cell survival after 96 hrs by SRB assay2015European journal of medicinal chemistry, Aug-28, Volume: 101Incorporation of a Michael acceptor enhances the antitumor activity of triterpenoic acids.
AID528065Cytotoxicity against human Lipo cells after 96 hrs by SRB assay2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
AID406994Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol at 20 uM2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries.
AID528055Cytotoxicity against human 8505C cells after 96 hrs by SRB assay2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
AID297147Inhibition of SARS virus-induced cytopathogenicity in Vero E6 cells at 3.3 uM2007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus.
AID623273Cytostatic activity against human U373 cells assessed as absence of induction of apoptosis at 80 uM after 48 to 72 hrs by TUNEL-based flow cytometric analysis2011Journal of medicinal chemistry, Oct-13, Volume: 54, Issue:19
N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
AID733167Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated IL-6 mRNA expression at 75 uM incubated for 2 hrs prior to LPS-challenge measured after 8 hrs by quantitative real time PCR analysis2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Discovery of a potential anti-inflammatory agent: 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile.
AID307010Cytotoxicity against human KB cells at 20 ug/mL by sulforhodamine B assay2007Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents.
AID356353Inhibition of testerone 5-alpha-reductase at 100 ug/mL2003Journal of natural products, Aug, Volume: 66, Issue:8
Phenolic constituents from Dalbergia cochinchinensis.
AID406995Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries.
AID548048Cytotoxicity against human A2780 cells after 96 hrs by sulforhodamine B assay2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
AID658063Cytotoxicity against human ECV304 cells after 72 hrs by Hoechst 33258 staining based fluorescence assay2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Saponins can perturb biologic membranes and reduce the surface tension of aqueous solutions: a correlation?
AID1418488Inhibition of LPS binding to TLR4 in IFNgamma-stimulated mouse RAW264.7 cells assessed as reduction in nitric oxide production at 25 to 100 uM pretreated for 2 hrs followed by LPS/IFNgamma stimulation and measured after 24 hrs2018Bioorganic & medicinal chemistry letters, 12-01, Volume: 28, Issue:22
Sentulic acid isolated from Sandoricum koetjape Merr attenuates lipopolysaccharide and interferon gamma co-stimulated nitric oxide production in murine macrophage RAW264 cells.
AID678714Inhibition of human CYP2C19 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 3-butyryl-7-methoxycoumarin as substrate after 30 mins2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID354423Cytotoxicity against human Raji cells assessed as cell viability at 0.32 nmol after 48 hrs by trypan blue assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Polyprenylated benzophenones from Garcinia assigu and their potential cancer chemopreventive activities.
AID300494Cytotoxicity against human KB-VIN cells by sulforhodamine B assay2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Anti-tumor agents 255: novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents.
AID1372142Inhibition of recombinant human CYP1A1 expressed in yeast microsomal membranes at 10 uM by fluorescence assay relative to control
AID1285101Selectivity ratio of IC50 for CE1 in human liver microsomes to IC50 for CE2 in human liver microsomes2016European journal of medicinal chemistry, Apr-13, Volume: 112Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2.
AID1578450Cytotoxicity against human A375 cells assessed as reduction in cell viability incubated for 96 hrs by SRB assay2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis and cytotoxicity of BODIPY FL labelled triterpenoids.
AID1634747Upregulation of yqhB expression in Bacillus subtilis ATCC 6051 at 0.5 times MIC by qRT-PCR analysis relative to control2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID1202732Selectivity ratio of IC50 for human 11beta-HSD2 to IC50 for human 11beta-HSD12015Journal of natural products, Feb-27, Volume: 78, Issue:2
Hupehenols A-E, selective 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors from Viburnum hupehense.
AID1568248Antiproliferative activity against human HepG2 cells incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Sep-15, Volume: 178Synthesis and biological activity of glycyrrhetinic acid derivatives as antitumor agents.
AID1069942Inhibition of ERK phosphorylation in human NCI-H460 cells at 12.5 to 50 uM after 24 hrs by Western blot analysis2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID307004Cytotoxicity against human 1A9 cells at 20 ug/mL by sulforhodamine B assay2007Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents.
AID1193496Thermodynamic equilibrium solubility, log S of the compound in water at RT after 24 hrs by shake-flask method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID300498Cytotoxicity against human 1A9 cells2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Anti-tumor agents 255: novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents.
AID527943Antiproliferative activity against human HepG2 cells after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellular carcinoma agents.
AID1484851Inhibition of full-length human 11beta-HSD1 expressed in HEK293 microsomal fraction using [3H]cortisone as substrate after 2 hr by scintillation proximity assay2017European journal of medicinal chemistry, Jul-28, Volume: 135Synthesis of selective 11β-HSD1 inhibitors based on dammarane scaffold.
AID1586616Inhibition of TNF-alpha induced NF-kappaB activation in human A549 cells after 7 hrs by Bright-Glo luciferase reporter gene assay2018Bioorganic & medicinal chemistry letters, 12-15, Volume: 28, Issue:23-24
Glycyrrhetinic acid derivatives containing aminophosphonate ester species as multidrug resistance reversers that block the NF-κB pathway and cell proliferation.
AID1069948Cell cycle arrest in human NCI-H460 cells assessed as accumulation at sub-G1 phase at 12.5 uM after 1 hr by propidium iodide staining-based flow cytometric analysis (Rvb = 2.2%)2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID1202729Inhibition of human 11beta-HSD1 overexpressed in microsomal fraction of HEK293 cells assessed as formation of [3H]-cortisol from [3H]-cortisone by scintillation proximity assay in presence of NADPH2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Hupehenols A-E, selective 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors from Viburnum hupehense.
AID1634724Antibacterial activity against Escherichia coli at 100 uM measured after 5 to 6 hrs by microdilution assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID300502Cytotoxicity against human DU145 cells2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Anti-tumor agents 255: novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents.
AID356319Antiinflammatory activity in mouse assessed as inhibition of TPA-induced ear edema at 430 nmol2003Journal of natural products, Aug, Volume: 66, Issue:8
Anti-inflammatory lanostane-type triterpene acids from Piptoporus betulinus.
AID1069938Induction of apoptosis in human NCI-H460 cells assessed as PARP cleavage at 50 uM after 24 hrs by Western blot analysis in presence of PKC promoter PMA, JNK inhibitor SP6001252014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID1069945Induction of apoptosis in human A549 cells assessed as PARP cleavage at 12.5 to 50 uM after 24 hrs by Western blot analysis2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID1617780Inhibition of human recombinant COX2 expressed in baculovirus infected sf21 cells assessed as decrease in PGE2 formation using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID551432Inhibition of recombinant SHP22011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs.
AID1391719Selectivity index, ratio of CC50 for human HepG2.215 cells to IC50 for Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBsAg secretion2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
AID623143Growth inhibition in apoptosis-resistant human U373 after 3 days by MTT assay2011Journal of medicinal chemistry, Oct-13, Volume: 54, Issue:19
N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
AID697021Inhibition of N-terminal 6His-tagged human AKR1B10 overexpressed in human HeLa cells assessed as inhibition of [1-14C]farnesol reduction at 1 uM pretreated for 2 hrs before [1-14C]farnesol challenge measured after 6 hrs2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID1515733Cytotoxicity against human Bel7402/5-FU cells assessed as cell growth inhibition after 48 hrs by MTT assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
Synthesis and antitumor activity of fluorouracil - oleanolic acid/ursolic acid/glycyrrhetinic acid conjugates.
AID456094Inhibition of rat renal 11beta-HSD2 in rat liver assessed as inhibition of cortisone production2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases.
AID1069947Cell cycle arrest in human NCI-H460 cells assessed as accumulation at sub-G1 phase at 25 uM after 1 hr by propidium iodide staining-based flow cytometric analysis (Rvb = 2.2%)2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID658065Reduction in surface tension in 0.1 M PBS after 10 mins by Wilhelmy plate method using tensitometer2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Saponins can perturb biologic membranes and reduce the surface tension of aqueous solutions: a correlation?
AID1917386Cytoprotective activity against UV-B irradiation induced human HDF cells assessed as increase in cell viability at 25 uM incubated for 24 hrs by MTT assay2022Bioorganic & medicinal chemistry letters, 11-15, Volume: 76Photoprotective effect of 18β-glycyrrhetinic acid derivatives against ultra violet (UV)-B-Induced skin aging.
AID307008Cytotoxicity against human PC3 cells at 20 ug/mL by sulforhodamine B assay2007Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents.
AID678712Inhibition of human CYP1A2 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using ethoxyresorufin as substrate after 30 mins2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID490290Induction of F-actin disruption in mouse r/m HM-SFME-1 cells assessed as disappearance of F-actin extension at IC50 after 8 hrs by confocal laser scanning microscopy2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: induction of actin disruption and tumor cell-selective toxicity.
AID548058Cytotoxicity against human SW480 cells after 96 hrs by sulforhodamine B assay2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
AID621960Activation of chymotrypsin-like activity of 20S proteasome in human U373 cells at 90 uM after 2 days by bioluminescence assay2011Journal of medicinal chemistry, Oct-13, Volume: 54, Issue:19
N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
AID1515726Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
Synthesis and antitumor activity of fluorouracil - oleanolic acid/ursolic acid/glycyrrhetinic acid conjugates.
AID490289Induction of F-actin disruption in mouse SFME cells assessed as F-actin extension at IC50 after 8 hrs by confocal laser scanning microscopy2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: induction of actin disruption and tumor cell-selective toxicity.
AID717316Growth inhibition of human KB cells by SRB assay2012Bioorganic & medicinal chemistry letters, Dec-15, Volume: 22, Issue:24
Synthesis and biological evaluation of novel spin labeled 18β-glycyrrhetinic acid derivatives.
AID758690Inhibition of mouse 11beta-HSD22013European journal of medicinal chemistry, Jul, Volume: 65Discovery and structure-activity relationships of ent-Kaurene diterpenoids as potent and selective 11β-HSD1 inhibitors: potential impact in diabetes.
AID1634745Reduction in p450 expression in Streptomyces scabiei CGMCC4.7610246 at 0.5 times MIC by qRT-PCR analysis relative to control2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID1069934Induction of apoptosis in human NCI-H460 cells assessed as DNA fragmentation after 24 hrs by DAPI staining-based TUNEL assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID528058Cytotoxicity against human A431 cells after 96 hrs by SRB assay2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
AID526979Inhibition of human recombinant 11beta-HSD1 expressed in HEK293 cells assessed as residual conversion of [1,2-3H]-cortisone to cortisol at 1 uM by scintillation counting2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
AID1193497Thermodynamic equilibrium solubility, log S of the compound PBS at pH 7.4 at RT after 24 hrs by shake-flask method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID1634744Reduction in narG expression in methicillin-resistant Staphylococcus aureus at 0.5 times MIC by qRT-PCR analysis relative to control2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID1656453Inhibition of rat liver beta-glucuronidase2020European journal of medicinal chemistry, Feb-01, Volume: 187Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.
AID1617775Inhibition of human recombinant 5-LOX expressed in insect cells assessed residual activity using arachidonic acid at 42 uM as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by ferric ion oxidation-xylenol o2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID409686Inhibition of PTP1B by pNPP assay2008Bioorganic & medicinal chemistry, Sep-15, Volume: 16, Issue:18
Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities.
AID1389864Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
Discovery of 18β-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance.
AID1634746Upregulation of yhdT expression in Bacillus subtilis ATCC 6051 at 0.5 times MIC by qRT-PCR analysis relative to control2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID528063Cytotoxicity against human HCT8 cells after 96 hrs by SRB assay2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
AID659369Selectivity index, ratio of CC50 for human HepG2(2.2.15) cells to IC50 for HBV by viral DNA replication detection assay2012Bioorganic & medicinal chemistry letters, May-15, Volume: 22, Issue:10
Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
AID354421Cytotoxicity against human Raji cells assessed as cell viability at 16 nmol after 48 hrs by trypan blue assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Polyprenylated benzophenones from Garcinia assigu and their potential cancer chemopreventive activities.
AID1180486Antiviral activity against VSV-G protein pseudotyped HIV1 infected in 293T cells assessed as inhibition of viral replication after 48 hrs by luciferase reporter assay2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Uralsaponins M-Y, antiviral triterpenoid saponins from the roots of Glycyrrhiza uralensis.
AID1414762Cytotoxicity activity against mouse B16F10 cells assessed as cell growth inhibition after 48 hrs by MTT assay2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids.
AID343738Inhibition of trypsin-like activity of human 20S proteasome2008Bioorganic & medicinal chemistry, Jul-15, Volume: 16, Issue:14
Synthesis and proteasome inhibition of glycyrrhetinic acid derivatives.
AID528064Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
AID1414760Cytotoxicity activity against mouse 4T1 cells assessed as cell growth inhibition after 48 hrs by MTT assay2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids.
AID409687Inhibition of TCPTP by pNPP assay2008Bioorganic & medicinal chemistry, Sep-15, Volume: 16, Issue:18
Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities.
AID528070Induction of apoptosis in human A549 cells at IC90 concentration after 24 to 48 hrs using acridine orange/ethidium bromide dye by fluorescence microscopic analysis2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
AID1389860Inhibition of His-tagged full-length Hsp90 (unknown origin)/GST-tagged Cdc37M (unknown origin) interaction after 1 hr by HTRF assay2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
Discovery of 18β-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance.
AID1372143Inhibition of human CYP1B1 expressed in yeast microsomal membranes at 10 uM using 7-ethoxyresorufin as substrate by fluorescence assay relative to control
AID1903421Anti-asthmatic activity against ovalbumin-induced asthmatic mouse model assessed as infiltration of inflammatory cells in the perivascular and peribronchiolar region of lungs at 20 mg/kg, po administered once daily for 7 days by H and E staining based lig
AID307006Cytotoxicity against human MCF7 cells at 20 ug/mL by sulforhodamine B assay2007Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents.
AID623267Growth inhibition in apoptosis-sensitive human MCF7 after 3 days by MTT assay2011Journal of medicinal chemistry, Oct-13, Volume: 54, Issue:19
N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
AID1693908Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by ATP based luminometry2021Bioorganic & medicinal chemistry, 01-15, Volume: 30Soloxolone methyl, as a 18βH-glycyrrhetinic acid derivate, may result in endoplasmic reticulum stress to induce apoptosis in breast cancer cells.
AID1243946Cytotoxicity against human 8505C cells assessed as cell survival after 96 hrs by SRB assay2015European journal of medicinal chemistry, Aug-28, Volume: 101Incorporation of a Michael acceptor enhances the antitumor activity of triterpenoic acids.
AID587120Inhibition of rat 11beta-HSD2 at 10 uM2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
AID977604Ki values for sodium fluorescein (10 uM) uptake in OATP1B3-transfected CHO cells2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID528056Cytotoxicity against human A253 cells after 96 hrs by SRB assay2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
AID1586627Growth inhibition of cisplatin-resistant human SKOV3/DDP cells after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 12-15, Volume: 28, Issue:23-24
Glycyrrhetinic acid derivatives containing aminophosphonate ester species as multidrug resistance reversers that block the NF-κB pathway and cell proliferation.
AID1250814Antiproliferative activity against human HeLa cells after 48 hrs by CCK-8 assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Design, synthesis, and biofunctional evaluation of novel pentacyclic triterpenes bearing O-[4-(1-piperazinyl)-4-oxo-butyryl moiety as antiproliferative agents.
AID733161Inhibition of IkappaBalpha degradation in mouse LPS-induced RAW264.7 cells assessed as increase in cytosolic IkappaB level at 75 uM incubated for 2 hrs prior to LPS-challenge measured after 30 mins by Western blot analysis2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Discovery of a potential anti-inflammatory agent: 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile.
AID1193495Thermodynamic equilibrium solubility, log S of the compound in simulated intestinal fluid at pH 6.8 at RT after 4 hrs by 96 well plate method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID1391716Antiviral activity against Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBsAg secretion after 3 days by ELISA2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
AID1634749Upregulation of hla expression in Staphylococcus aureus ATCC 25923 at 0.5 times MIC by qRT-PCR analysis relative to control2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID1250815Antiproliferative activity against human A549 cells after 48 hrs by CCK-8 assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Design, synthesis, and biofunctional evaluation of novel pentacyclic triterpenes bearing O-[4-(1-piperazinyl)-4-oxo-butyryl moiety as antiproliferative agents.
AID548050Cytotoxicity against human DLD1 cells after 96 hrs by sulforhodamine B assay2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
AID733176Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production at 50 uM incubated for 2 hrs prior to LPS-challenge measured after 24 hrs by Griess method2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Discovery of a potential anti-inflammatory agent: 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1069939Induction of apoptosis in human NCI-H460 cells assessed as caspase-3 cleavage at 50 uM after 24 hrs by Western blot analysis in presence of PKC promoter PMA, JNK inhibitor SP6001252014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID1243948Cytotoxicity against human HT-29 cells assessed as cell survival after 96 hrs by SRB assay2015European journal of medicinal chemistry, Aug-28, Volume: 101Incorporation of a Michael acceptor enhances the antitumor activity of triterpenoic acids.
AID1285100Inhibition of CE1 in human liver microsomes using 2-(2-Benzoyl-3-methoxyphenyl) benzothiazole as substrate preincubated for 10 mins followed by substrate addition measured after 30 mins by LC-UV analysis2016European journal of medicinal chemistry, Apr-13, Volume: 112Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2.
AID456096Inhibition of human recombinant 11beta-HSD2 expressed in HEK293 cells assessed as oxidation of [1,2,6,7-3H]cortisol to cortisone up to 20 uM after 10 mins by scintillation counting2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases.
AID1363019Inhibition of human 11beta-HSD1 expressed in HEK293 cell lysates assessed as remaining enzyme activity at 1 uM using radiolabeled cortisone as substrate incubated for 10 mins by scintillation counting method relative to control2018Bioorganic & medicinal chemistry, 10-01, Volume: 26, Issue:18
Design, synthesis, and biological evaluation of novel selective peptide inhibitors of 11β-hydroxysteroid dehydrogenase 1.
AID401475Cytotoxicity in Wistar rat hepatocytes assessed as glutamic-pyruvic transaminase activity at 0.1 mg/ml after 30 hrs
AID1069943Inhibition of PKC alpha/beta-2 phosphorylation in human NCI-H460 cells at 12.5 to 50 uM after 24 hrs by Western blot analysis2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID1202734Selectivity ratio of IC50 for mouse 11beta-HSD2 to IC50 for mouse 11beta-HSD12015Journal of natural products, Feb-27, Volume: 78, Issue:2
Hupehenols A-E, selective 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors from Viburnum hupehense.
AID380239Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as number of skin papillomas per mouse at 85 nmol administered twice weekly after 1 week of initiation for 20 weeks1999Journal of natural products, Jul, Volume: 62, Issue:7
Cancer chemopreventive agents (antitumor-promoters) from Ajuga decumbens.
AID659366Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B e-antigen release2012Bioorganic & medicinal chemistry letters, May-15, Volume: 22, Issue:10
Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
AID1634751Inhibition of hla expression in methicillin-resistant Staphylococcus aureus at 0.5 times MIC by qRT-PCR analysis relative to control2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID733172Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced iNOS protein expression at 75 uM incubated for 2 hrs prior to LPS-challenge measured after 24 hrs by Western blot analysis2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Discovery of a potential anti-inflammatory agent: 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile.
AID678722Covalent binding affinity to human liver microsomes assessed per mg of protein at 10 uM after 60 mins presence of NADPH2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID1069937Inhibition of PKC alpha/beta-2 phosphorylation in human NCI-H460 cells at 50 uM after 24 hrs by Western blot analysis in presence of PKC promoter PMA, JNK inhibitor SP6001252014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID1634726Antibacterial activity against multi-drug resistant Pseudomonas aeruginosa at 100 uM measured after 5 to 6 hrs by microdilution assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID307009Cytotoxicity against human DU145 cells at 20 ug/mL by sulforhodamine B assay2007Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents.
AID1634754Inhibition of mouse microsomal 11beta-HSD1 overexpressed in HEK293 cells using [3H]-cortisone as substrate assessed as formation of [3H]-cortisol using [3H]cortisone by scintillation proximity assay in presence of NADPH2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Limonoids and Triterpenoids as 11β-HSD1 Inhibitors from Walsura robusta.
AID1069936Cell cycle arrest in human NCI-H460 cells assessed as accumulation at sub-G1 phase at 50 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis in presence of PKC promoter PMA, JNK inhibitor SP6001252014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID1193493Thermodynamic equilibrium solubility, log S of the compound in PBS at pH 7.4 at RT after 4 hrs by 96 well plate method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID1069946Cell cycle arrest in human NCI-H460 cells assessed as accumulation at sub-G1 phase at 50 uM after 1 hr by propidium iodide staining-based flow cytometric analysis (Rvb = 2.2%)2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID733159Inhibition of IkappaBalpha in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated NF-kappaB p65 subunit accumulation in nucleus at 75 uM incubated for 2 hrs prior to LPS-challenge measured after 30 mins by Western blot analysis2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Discovery of a potential anti-inflammatory agent: 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile.
AID977601Ki values for sodium fluorescein (10 uM) uptake in OATP1B1-transfected CHO cells2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1069932Cytotoxicity against human NCI-H460 cells assessed as cell viability after 24 hrs by XTT assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID1578453Cytotoxicity against human A2780 cells assessed as reduction in cell viability incubated for 96 hrs by SRB assay2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis and cytotoxicity of BODIPY FL labelled triterpenoids.
AID1464037Inhibition of Pin1 (unknown origin) assessed as reduction in peptidyl-prolyl isomerase activity at 10 uM incubated for 30 mins using Suc-Ala-Glu-cis-Pro-Phe-4-nitroanilide substrate by protease coupled assay2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Conjugates of 18β-glycyrrhetinic acid derivatives with 3-(1H-benzo[d]imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability.
AID1515728Cytotoxicity against human Bel7402 cells assessed as cell growth inhibition after 48 hrs by MTT assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
Synthesis and antitumor activity of fluorouracil - oleanolic acid/ursolic acid/glycyrrhetinic acid conjugates.
AID337577Inhibition of rat liver 3-ketosteroid 5-beta-reductase1993Journal of natural products, Feb, Volume: 56, Issue:2
Production of an anti-allergic triterpene bryonolic acid, by plant cell cultures.
AID621453Inhibition of human 11beta HSD1 expressed in HEK293 cells assessed as assessed as inhibition of [1,2-(n)3H]cortisone to [3H]-cortisol after 60 mins by scintillation proximity assay2011Bioorganic & medicinal chemistry letters, Oct-01, Volume: 21, Issue:19
Potent and novel 11β-HSD1 inhibitors identified from shape and docking based virtual screening.
AID1414763Cytotoxicity activity against human PANC1 cells assessed as cell growth inhibition after 48 hrs by MTT assay2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids.
AID1873243Anti-obesity activity in male C57BL/6 mouse model of high-fat diet induced obesity assessed as body weight change at 30 mg/kg, po administered once a day for 8 weeks relative to control2022European journal of medicinal chemistry, Jul-05, Volume: 237Recent advances in natural anti-obesity compounds and derivatives based on in vivo evidence: A mini-review.
AID1586618Antiproliferative activity against human NCI-H460 cells after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 12-15, Volume: 28, Issue:23-24
Glycyrrhetinic acid derivatives containing aminophosphonate ester species as multidrug resistance reversers that block the NF-κB pathway and cell proliferation.
AID758687selectivity ratio of IC50 for human 11beta-HSD2 to IC50 for human 11beta-HSD12013European journal of medicinal chemistry, Jul, Volume: 65Discovery and structure-activity relationships of ent-Kaurene diterpenoids as potent and selective 11β-HSD1 inhibitors: potential impact in diabetes.
AID548045Cytotoxicity against human 518A2 cells after 96 hrs by sulforhodamine B assay2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
AID548046Cytotoxicity against human 8505C cells after 96 hrs by sulforhodamine B assay2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
AID758691Selectivity ratio of IC50 for mouse 11beta-HSD2 to IC50 for mouse 11beta-HSD12013European journal of medicinal chemistry, Jul, Volume: 65Discovery and structure-activity relationships of ent-Kaurene diterpenoids as potent and selective 11β-HSD1 inhibitors: potential impact in diabetes.
AID490287Antiproliferative activity against mouse r/m HM-SFME-1 cells after 24 hrs by MTT assay2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: induction of actin disruption and tumor cell-selective toxicity.
AID1372448Expectorant activity in ICR mouse assessed as increase in phenol red secretion in trachea at 50 mg/kg, po for 3 days followed by phenol red treatment at 30 mins post last dose measured after 30 mins by UV-Vis spectrophotometric assay relative to control2018Bioorganic & medicinal chemistry, 01-01, Volume: 26, Issue:1
Antitussive and expectorant activities of licorice and its major compounds.
AID623275Cell cycle arrest in human U373 cells assessed as accumulation of cells in G1 phase at 80 uM after 48 to 72 hrs by TUNEL-based flow cytometric analysis2011Journal of medicinal chemistry, Oct-13, Volume: 54, Issue:19
N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
AID758688Inhibition of human 11beta-HSD1 expressed in HEK293 cell microsomes assessed as inhibition of [3H]cortisone conversion to [3H]cortisol by scintillation proximity assay2013European journal of medicinal chemistry, Jul, Volume: 65Discovery and structure-activity relationships of ent-Kaurene diterpenoids as potent and selective 11β-HSD1 inhibitors: potential impact in diabetes.
AID678713Inhibition of human CYP2C9 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-methoxy-4-trifluoromethylcoumarin-3-acetic acid as substrate after 30 mins2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID354422Cytotoxicity against human Raji cells assessed as cell viability at 3.2 nmol after 48 hrs by trypan blue assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Polyprenylated benzophenones from Garcinia assigu and their potential cancer chemopreventive activities.
AID1416421Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production at 40 uM preincubated for 2 hrs followed by LPS addition measured after 20 hrs by Griess assay relative to control2017MedChemComm, Jul-01, Volume: 8, Issue:7
18α-Glycyrrhetinic acid monoglucuronide as an anti-inflammatory agent through suppression of the NF-κB and MAPK signaling pathway.
AID356352Inhibition of testerone 5-alpha-reductase at 50 ug/mL2003Journal of natural products, Aug, Volume: 66, Issue:8
Phenolic constituents from Dalbergia cochinchinensis.
AID733153Inhibition of ERK phosphorylation in mouse LPS-induced RAW264.7 cells at 75 uM incubated for 2 hrs prior to LPS-challenge measured after 30 mins by Western blot analysis2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Discovery of a potential anti-inflammatory agent: 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile.
AID1484853Inhibition of full-length human 11beta-HSD2 expressed in HEK293 microsomal fraction using [3H]cortisone as substrate after 2 hr by scintillation proximity assay2017European journal of medicinal chemistry, Jul-28, Volume: 135Synthesis of selective 11β-HSD1 inhibitors based on dammarane scaffold.
AID678715Inhibition of human CYP2D6 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 4-methylaminoethyl-7-methoxycoumarin as substrate after 30 mins2012Chemical research in toxicology, Oct-15, Volume: 25, Issue:10
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
AID621942Activation of PPARgamma activity in human U373 cells at 7 uM after 6 hrs by spectrophotometric analysis relative to control2011Journal of medicinal chemistry, Oct-13, Volume: 54, Issue:19
N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
AID658066Critical micellar concentration of the compound in 0.1 M PBS after 10 mins by Wilhelmy plate method using tensitometer2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Saponins can perturb biologic membranes and reduce the surface tension of aqueous solutions: a correlation?
AID623276Cell cycle arrest in human A549 cells assessed as accumulation of cells in G1 phase at 100 uM after 48 to 72 hrs by TUNEL-based flow cytometric analysis2011Journal of medicinal chemistry, Oct-13, Volume: 54, Issue:19
N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
AID352313Inhibition of human 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay in presence of NADPH2009European journal of medicinal chemistry, Mar, Volume: 44, Issue:3
Structure-based virtual screening for identification of novel 11beta-HSD1 inhibitors.
AID354416Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 32 nmol after 48 hrs relative to TPA2003Journal of natural products, Feb, Volume: 66, Issue:2
Polyprenylated benzophenones from Garcinia assigu and their potential cancer chemopreventive activities.
AID300500Cytotoxicity against human ZR751 cells2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Anti-tumor agents 255: novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents.
AID1688022Antiproliferative activity against human HL-60 cells assessed as cell growth inhibition after 72 hrs by trypan blue staining based cell counting assay2020European journal of medicinal chemistry, Feb-15, Volume: 188A 18β-glycyrrhetinic acid conjugate with Vorinostat degrades HDAC3 and HDAC6 with improved antitumor effects.
AID614021Inhibition of Streptococcus agalactiae hyaluronidase2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID600419Selectivity index, ratio of CD50 for human MT4 cells to ID50 for HIV12009Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14
Novel 3alpha-methoxyserrat-14-en-21beta-ol (PJ-1) and 3beta-methoxyserrat-14-en-21beta-ol (PJ-2)-curcumin, kojic acid, quercetin, and baicalein conjugates as HIV agents.
AID621961Inhibition of trypsin-like activity of 20S proteasome in human U373 cells at 90 uM after 2 days by bioluminescence assay2011Journal of medicinal chemistry, Oct-13, Volume: 54, Issue:19
N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
AID380238Inhibition of DMBA-induced/TPA-promoted carcinogenesis in mouse assessed as number of skin papillomas per mouse at 85 nmol administered twice weekly after 1 week of initiation for 10 weeks1999Journal of natural products, Jul, Volume: 62, Issue:7
Cancer chemopreventive agents (antitumor-promoters) from Ajuga decumbens.
AID1586620Antiproliferative activity against human A549 cells after 48 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 12-15, Volume: 28, Issue:23-24
Glycyrrhetinic acid derivatives containing aminophosphonate ester species as multidrug resistance reversers that block the NF-κB pathway and cell proliferation.
AID1069931Induction of apoptosis in human NCI-H460 cells assessed as PARP cleavage at 12.5 to 50 uM after 24 hrs by Western blot analysis2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID526984Selectivity ratio of IC50 for human recombinant 11beta-HSD2 to IC50 for human recombinant 11beta-HSD12010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
AID1069944Cell cycle arrest in human A549 cells assessed as accumulation at sub-G1 phase at 50 uM after 1 hr by propidium iodide staining-based flow cytometric analysis2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID404873Inhibition of rabbit muscle glycogen phosphorylase A assessed as phosphate release from glucose-1-phosphate2008Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies.
AID1391720Selectivity index, ratio of CC50 for human HepG2.215 cells to IC50 for Hepatitis B virus infected in human HepG2.215 cells assessed as inhibition of HBeAg secretion2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
AID528067Cytotoxicity against human SW1736 cells after 96 hrs by SRB assay2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
AID456093Inhibition of 11beta-HSD1 in rat liver assessed as cortisone level2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases.
AID1634743Reduction in narG expression in Staphylococcus aureus ATCC 25923 at 0.5 times MIC by qRT-PCR analysis relative to control2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID623142Growth inhibition in apoptosis-resistant human T98G after 3 days by MTT assay2011Journal of medicinal chemistry, Oct-13, Volume: 54, Issue:19
N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
AID307005Cytotoxicity against human A549 cells at 20 ug/mL by sulforhodamine B assay2007Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents.
AID1728066Activation of AMPK in human Huh-7 cells assessed as increase in AMPK phosphorylation at Thr172 residue at 10 uM measured after 12 hrs by Western blot analysis2021European journal of medicinal chemistry, Jan-01, Volume: 209Synthesis and anti-inflammatory activity of saponin derivatives of δ-oleanolic acid.
AID1568250Cytotoxicity against MDCK cells incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Sep-15, Volume: 178Synthesis and biological activity of glycyrrhetinic acid derivatives as antitumor agents.
AID1069929Induction of apoptosis in human NCI-H460 cells assessed as downregulation of Bcl-xL protein expression at 12.5 to 50 uM after 24 hrs by Western blot analysis2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID1903445Anti-asthmatic activity against ovalbumin-induced asthmatic mouse model assessed as decrease in IgE level in serum at 20 mg/kg, po administered once daily for 7 days by ELISA
AID1903446Anti-asthmatic activity against ovalbumin-induced asthmatic mouse model assessed as decrease in IL-4 level in BALF at 20 mg/kg, po administered once daily for 7 days by ELISA
AID1464038Inhibition of Pin1 (unknown origin) assessed as reduction in peptidyl-prolyl isomerase activity incubated for 30 mins using Suc-Ala-Glu-cis-Pro-Phe-4-nitroanilide substrate by protease coupled assay2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Conjugates of 18β-glycyrrhetinic acid derivatives with 3-(1H-benzo[d]imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability.
AID1500921Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production by measuring nitrite level at 40 uM pretreated for 2 hrs followed by LPS challenge measured after 24 hrs by Griess assay relative to control2017European journal of medicinal chemistry, Oct-20, Volume: 139Novel unsaturated glycyrrhetic acids derivatives: Design, synthesis and anti-inflammatory activity.
AID1069941Induction of PKC-delta phosphorylation in human NCI-H460 cells at 12.5 to 50 uM after 24 hrs by Western blot analysis2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID1662293Cytotoxicity against mouse RAW264.7 cells assessed as cell viability2020Bioorganic & medicinal chemistry, 06-01, Volume: 28, Issue:11
Microbial transformation of glycyrrhetinic acid derivatives by Bacillus subtilis ATCC 6633 and Bacillus megaterium CGMCC 1.1741.
AID490292Down regulation of beta-actin protein expression in mouse SFME cells at IC50 after 8 hrs by Western blotting2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: induction of actin disruption and tumor cell-selective toxicity.
AID1634750Inhibition of seaR expression in methicillin-resistant Staphylococcus aureus at 0.5 times MIC by qRT-PCR analysis relative to control2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID697009Inhibition of reductase activity of N-terminal 6His-tagged human AKR1B10 expressed in Escherichia coli BL21(DE3) assessed as pyridine-3-aldehyde reduction2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID1453348Inhibition of recombinant human 11beta-HSD1 expressed in HEK293 cells assessed as residual activity at 20 uM using cortisone as substrate after 10 mins in presence of radiolabeled tracer substrate by scintillation counting method relative to control2017Bioorganic & medicinal chemistry letters, 07-01, Volume: 27, Issue:13
Phenylbenzenesulfonates and -sulfonamides as 17β-hydroxysteroid dehydrogenase type 2 inhibitors: Synthesis and SAR-analysis.
AID1391718Cytotoxicity against human HepG2.215 cells assessed as reduction in cell viability after 3 days by MTT assay2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
AID490288Antiproliferative activity against mouse r/m HM-SFME-1 cells at 10 uM after 24 hrs by MTT assay2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: induction of actin disruption and tumor cell-selective toxicity.
AID733152Antiinflammatory activity in ICR mouse assessed as protection against LPS-induced sepsis at 50 mg/kg, ip administered for 5 days prior to LPS-challenge measured after 2 hrs2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Discovery of a potential anti-inflammatory agent: 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile.
AID1069951Induction of apoptosis in human NCI-H460 cells assessed as downregulation of Bcl-2 protein expression at 12.5 to 50 uM after 24 hrs by Western blot analysis2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
AID1578451Cytotoxicity against human HT-29 cells assessed as reduction in cell viability incubated for 96 hrs by SRB assay2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis and cytotoxicity of BODIPY FL labelled triterpenoids.
AID401476Cytotoxicity in Wistar rat hepatocytes assessed as glutamic-pyruvic transaminase activity at 1 mg/ml after 30 hrs
AID977600pIC50 values for sodium fluorescein (10 uM) uptake in OATP1B1-transfected CHO cells2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1431435Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1634748Upregulation of seaR expression in Staphylococcus aureus ATCC 25923 at 0.5 times MIC by qRT-PCR analysis relative to control2016Journal of natural products, Apr-22, Volume: 79, Issue:4
18β-Glycyrrhetinic Acid Derivatives Possessing a Trihydroxylated A Ring Are Potent Gram-Positive Antibacterial Agents.
AID307011Cytotoxicity against multi drug-resistant human KBVIN cells at 20 ug/mL by sulforhodamine B assay2007Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents.
AID528060Cytotoxicity against human DLD1 cells after 96 hrs by SRB assay2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1224864HCS microscopy assay (F508del-CFTR)2016PloS one, , Volume: 11, Issue:10
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (101)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (1.98)18.2507
2000's18 (17.82)29.6817
2010's65 (64.36)24.3611
2020's16 (15.84)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (4.90%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other97 (95.10%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (6)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Single-center Prospective Randomized Study of Glycyrrhetinic Acid Combined With Dexamethasone in the Treatment of Newly Diagnosed Primary Immune Thrombocytopenia (ITP) [NCT03998982]Phase 430 participants (Anticipated)Interventional2019-06-25Recruiting
A Randomized, Comparator-controlled, Double-blind, Multicenter Intra-individual Clinical Trial to Evaluate the Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic Dermatitis [NCT01079897]64 participants (Actual)Interventional2010-03-31Completed
Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis Patients [NCT00384384]Phase 224 participants Interventional2006-08-31Completed
The Role of Mineralocorticoid Receptors in Vascular Function [NCT00759525]Phase 2/Phase 315 participants (Actual)Interventional2002-02-28Completed
Double-blind Randomized Placebo Controlled Study on the Effect of Enoxolone ( 11-beta Hydroxysteroid-dehydrogenase Type 2 Inhibitor) on the RAAS, Autonomic and Imaging Biomarkers and the Outcome of Depression [NCT05570110]Phase 1/Phase 260 participants (Anticipated)Interventional2022-09-23Recruiting
Effectiveness of Enoxolone on Oral Conditions of Patients With Periodontal Surgery [NCT05987722]27 participants (Actual)Interventional2021-07-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

TrialOutcome
NCT00759525 (1) [back to overview]Forearm Blood Flow

Forearm Blood Flow

At the end of each 14-day intervention (Glycyrrhinitic acid or Placebo), vascular endothelial function was assessed by measuring forearm blood flow and comparing to Baseline. The outcome measure depicted below reflects the change in forearm blood flow from Baseline after completing the glycyrrhinitic acid regimen as well as the change in forearm blood flow from Baseline after taking the matching placebo. (NCT00759525)
Timeframe: Outcome was measured at the end of each study period (i.e. 14 days after Baseline measurements were taken)

Interventionml/100ml of tissue/min (Mean)
Glycyrrhinitic Acid1.87
Placebo1.34

[back to top]